Selected Publications
ZMB Publications
Selected Publications
The list provides selected publications of the ZMB from 2004 to 2021, published in the journals listed below.
You can narrow the list down by year and author. If an error accured or no data was found, please reload or reset the page.
(View all ZMB publications via the interface of the university bibliography).
Journals
- ACS Nano
- Acta Neuropathologica
- Advanced Drug Delivery Reviews
- All Nature Journals
- American Journal of Human Genetics
- Angewandte Chemie International Edition
- Annals of Oncology
- Annual Review of Biochemistry
- Annual Review of Genetics
- Annual Review of Microbiology
- Biomaterials
- Biotechnology Advances
- Blood
- Brain
- Cancer Cell
- Cancer Discovery
- Cancer Research
- Cell
- Clinical Cancer Research
- Cell Reports
- Chemical Reviews
- Chemical Society Reviews
- Circulation
- Circulation Research
- Current Biology
- eLife
- EMBO Molecular Medicine
- EMBO Reports
- Endocrine Reviews
- European Heart Journal
- FEMS Microbiology Reviews
- Gastroenterology
- Genes and Development
- Gut
- Hepatology
- Immunity
- Immunological Reviews
- JAMA: Journal of the American Medical Association
- JAMA Oncology
- JAMA Neurology
- Journal of Hepatology
- Journal of the American Chemical Society
- Journal of the American Medical Association
- Journal of Clinical Oncology
- Journal of Hepatology
- Lancet
- Leukemia
- Molecular Cell
- Molecular Psychiatry
- Natural Product Research
- Nature
- Nature Biotechnology
- Nature Cancer
- Nature Cell Biology
- Nature Chemical Biology
- Nature Communications
- Nature Genetics
- Nature Medicine
- Nature Methods
- Nature Nanotechnology
- Nature Reviews Clinical Oncology
- Nature Reviews Molecular Cell Biology
- Nature Reviews Neurology
- Nature Structural & Molecular Biology
- Neuro-Oncology
- Nucleic Acids Research
- Proceedings of the National Academy of Sciences of the United States of America Science
- Science
- Science Advances
- Small
- The British Journal of Cancer
- The EMBO Journal
- The Journal of Cell Biology
- The Journal of Clinical Investigation (JCI)
- The Lancet
- The Lancet Diabetes and Endocrinology
- The Lancet Gastroenterology & Hepatology
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The New England Journal of Medicine
- Trends in Neurosciences
- Trends in Pharmacological Sciences
There were 1148 publications found
-
CCooperative Active Sites on Ag2Pt3TiS6 for Enhanced Low-Temperature Ammonia Fuel Cell ElectrocatalysisIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 6, e202418691 , in pressDOI (Open Access)
-
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancerIn: Nature Communications, Vol. 16, 2025, Nr. 1, 335DOI (Open Access)
-
Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophreniaIn: Molecular Psychiatry, Vol. 30, 2025, Nr. 7, pp. 2891 – 2906DOI (Open Access)
-
msiFlow : automated workflows for reproducible and scalable multimodal mass spectrometry imaging and microscopy data analysisIn: Nature Communications, Vol. 16, 2025, Nr. 1, 1065DOI (Open Access)
-
Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitorsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 3208DOI (Open Access)
-
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced MelanomaIn: The New England Journal of Medicine, Vol. 392, 2025, Nr. 1, pp. 11 – 22DOI, Online Full Text (Open Access)
-
Nitro-oleic acid enhances mitochondrial metabolism and ameliorates heart failure with preserved ejection fraction in miceIn: Nature Communications, Vol. 16, 2025, Nr. 1, 3933DOI (Open Access)
-
Aspartate signalling drives lung metastasis via alternative translationIn: Nature, Vol. 638, 2025, Nr. 2, pp. 244 – 250
-
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemiaIn: Blood, Vol. 145, 2025, Nr. 17, pp. 1943 – 1956
-
Discordance, accuracy and reproducibility study of pathologists’ diagnosis of melanoma and melanocytic tumorsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 789DOI (Open Access)
-
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse ModelsIn: Cancer Research, Vol. 85, 2025, Nr. 10, pp. 1769 – 1783
-
Cutaneous melanoma : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upIn: Annals of Oncology, Vol. 36, 2025, Nr. 1, pp. 10 – 30
-
Genetic and functional analyses of CTBP2 in anorexia nervosa and body weight regulationIn: Molecular Psychiatry, Vol. 30, 2025, Nr. 5, pp. 1836 – 1846DOI (Open Access)
-
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicityIn: Nature Communications, Vol. 16, 2025, Nr. 1, 2110DOI (Open Access)
-
Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis and correlate with thrombus resolutionIn: Immunity, Vol. 58, 2025, Nr. 5, pp. 1343 – 1358.e13DOI (Open Access)
-
In situ Cyclization of Aromatic Thioethers in Emissive Materials to Generate Phosphorescent DibenzothiophenesIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 2, e202414326DOI (Open Access)
-
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationIn: Journal of Hepatology, Vol. 82, 2025, Nr. 5, pp. 805 – 815DOI (Open Access)
-
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialIn: Nature Medicine, Vol. 31, 2025, Nr. 1, pp. 152 – 164DOI (Open Access)
-
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityIn: Cancer Cell, Vol. 43, 2025, Nr. 2, pp. 269 – 291.e19DOI (Open Access)
-
Immune training enhances anti-viral responses and improves outcomes in Pax5−/⁺ mice susceptible to chronic infectionIn: EMBO Molecular Medicine, Vol. 17, 2025, Nr. 4, pp. 696 – 721DOI (Open Access)
-
A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrilsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 2992DOI (Open Access)
-
Lack of AtMC1 catalytic activity triggers autoimmunity dependent on NLR stabilityIn: EMBO Reports, Vol. 26, 2025, Nr. 9, pp. 2378 – 2412DOI (Open Access)
-
High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non-Small Cell Lung Cancer in PatientsIn: Cancer Discovery, Vol. 15, 2025, Nr. 4, pp. 702 – 716DOI (Open Access)
-
Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistanceIn: Nature Communications, Vol. 16, 2025, Nr. 1, 5387DOI (Open Access)
-
Oxygen evolution reaction on IrO₂(110) is governed by Walden-type mechanismsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 6137DOI (Open Access)
-
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047In: Clinical Cancer Research, Vol. 31, 2025, Nr. 17, pp. 3702 – 3714DOI (Open Access)
-
Fulminant myocarditis : outcome predictors in an international cohort studyIn: European Heart Journal, 2025, in press
-
The BUB1 and BUBR1 paralogs scaffold the kinetochore fibrous coronaIn: Science Advances, Vol. 11, 2025, Nr. 37, eady6890DOI (Open Access)
-
Small Molecule-Induced Alterations of Protein Polyubiquitination Revealed by Mass-Spectrometric Ubiquitome AnalysisIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 32, e202508916DOI (Open Access)
-
Influence of Resuscitated Cardiac Arrest on Efficacy and Safety of Extracorporeal Life Support in Infarct-Related Cardiogenic Shock : A Substudy of the ECLS-SHOCK TrialIn: Circulation, Vol. 151, 2025, Nr. 24, pp. 1752 – 1754
-
Bacterial pathogen deploys the iminosugar glycosyrin to manipulate plant glycobiologyIn: Science, Vol. 388, 2025, Nr. 6744, pp. 297 – 303
-
Intermetallic Platinum-Calcium Alloy Breaks the Activity-Stability Trade-Off in Fuel Cell for Enhanced PerformanceIn: Small, Vol. 21, 2025, Nr. 31, 2503692DOI (Open Access)
-
Muscle growth by sarcomere divisionsIn: Science Advances, Vol. 11, 2025, Nr. 28, eadw9445DOI (Open Access)
-
Renaissance of Chlorine Evolution Reaction : Emerging Theory and Catalytic MaterialsIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 1, e202417293DOI (Open Access)
-
[⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation : A single-centre, single-arm, interventional, phase 2 trialIn: The Lancet Oncology, Vol. 26, 2025, Nr. 9, pp. 1204 – 1214DOI (Open Access)
-
Functional synapses between neurons and small cell lung cancerIn: Nature, Vol. 646, 2025, Nr. 8087, pp. 1243 – 1253DOI (Open Access)
-
Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivoIn: EMBO Molecular Medicine, 2025, in pressDOI (Open Access)
-
Adjuvant nivolumab and relatlimab in stage III/IV melanoma : the randomized phase 3 RELATIVITY-098 trialIn: Nature Medicine, 2025, in pressDOI (Open Access)
-
Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signalingIn: Nature Communications, Vol. 16, 2025, Nr. 1, 8928DOI (Open Access)
-
Interplay of kinetochores and catalysts drives rapid assembly of the mitotic checkpoint complexIn: Nature Communications, Vol. 16, 2025, Nr. 1, 4823DOI (Open Access)
-
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based ChemotherapyIn: The New England Journal of Medicine, Vol. 393, 2025, Nr. 4, pp. 349 – 361
-
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblingsIn: Leukemia, Vol. 39, 2025, Nr. 10, pp. 2523 – 2532DOI (Open Access)
-
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanomaIn: Annals of Oncology, Vol. 36, 2025, Nr. 10, pp. 1166 – 1177DOI (Open Access)
-
The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITAIn: eLife, Vol. 14, 2025, e96414DOI, Online Full Text (Open Access)
-
Conformational plasticity of a BiP-GRP94 chaperone complexIn: Nature Structural & Molecular Biology, Vol. 32, 2025, Nr. 10, pp. 1947 – 1958DOI (Open Access)
-
Lymphoma accelerates T cell and tissue agingIn: Cancer Cell, Vol. 43, 2025, Nr. 10, pp. 1917 – 1936.e8DOI (Open Access)
-
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trialIn: Nature Communications, Vol. 16, 2025, Nr. 1, 5919DOI (Open Access)
-
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencingIn: Leukemia, Vol. 39, 2025, Nr. 9, pp. 2215 – 2225DOI (Open Access)
-
Gemtuzumab ozogamicin in first-line treatment of CBF-AML : Insights from a retrospective multi-center analysisIn: Leukemia, Vol. 39, 2025, Nr. 9, pp. 2174 – 2180DOI (Open Access)
-
Multistate kinetics of the syringe-like injection mechanism of Tc toxinsIn: Science Advances, Vol. 11, 2025, Nr. 1, eadr2019DOI (Open Access)
-
Clinical validation of droplet digital PCR assays in detecting BRAFV⁶⁰⁰-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD) : A biomarker analysis from a double-blind, randomised phase 3 trialIn: The Lancet Oncology, Vol. 26, 2025, Nr. 5, pp. 641 – 653
-
IL-10 sensing by lung interstitial macrophages prevents bacterial dysbiosis-driven pulmonary inflammation and maintains immune homeostasisIn: Immunity, Vol. 58, 2025, Nr. 5, pp. 1306 – 1326.e7DOI (Open Access)
-
Common origin and somatic mutation patterns of composite lymphomas and leukemiasIn: Leukemia, Vol. 39, 2025, Nr. 8, pp. 1960 – 1971DOI (Open Access)
-
Approaches to stable isotope tracing and in vivo metabolomics in the cancer clinicIn: The EMBO Journal, Vol. 44, 2025, Nr. 12, pp. 3303 – 3306DOI (Open Access)
-
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaIn: Cell Reports, Vol. 44, 2025, Nr. 4, 115541DOI (Open Access)
-
CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphomaIn: Nature Communications, Vol. 16, 2025, Nr. 1, 4967DOI (Open Access)
-
The Spc105/Kre28 complex promotes mitotic error correction by outer kinetochore recruitment of Ipl1/Sli15In: The EMBO Journal, Vol. 44, 2025, Nr. 12, pp. 3492 – 3520DOI (Open Access)
-
Diet modulates the therapeutic effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCAR2In: eLife, Vol. 14, 2025, e98970DOI (Open Access)
-
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancerIn: Nature Medicine, Vol. 31, 2025, Nr. 8, pp. 2755 – 2767DOI (Open Access)
-
Selenoprotein O Promotes Melanoma Metastasis and Regulates Mitochondrial Complex II ActivityIn: Cancer Research, Vol. 85, 2025, Nr. 5, pp. 942 – 955DOI (Open Access)
-
Final overall survival and safety analyses of the phase III PSMAfore trial of [¹⁷⁷Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancerIn: Annals of Oncology, Vol. 36, 2025, Nr. 11, pp. 1319 – 1330DOI (Open Access)
-
Attenuated growth factor signaling during cell death initiation sensitizes membranes towards peroxidationIn: Nature Communications, Vol. 16, 2025, Nr. 1, 1774DOI, Online Full Text (Open Access)
-
CSF1R⁺ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphomaIn: Cancer Cell, Vol. 43, 2025, Nr. 8, pp. 1476 – 1494.e10DOI (Open Access)
-
Hypoxic-ischemic brain injury in neonatal mice sequentially recruits neutrophils with dichotomous phenotype and functionIn: Nature Communications, Vol. 16, 2025, Nr. 1, 9696DOI (Open Access)
-
TXNIP mediates LAT1/SLC7A5 endocytosis to limit amino acid uptake in cells entering quiescenceIn: The EMBO Journal, Vol. 44, 2025, Nr. 23, pp. 7119 – 7153DOI, Online Full Text (Open Access)
-
Polyamines sustain epithelial regeneration in aged intestines by modulating protein homeostasisIn: Nature Cell Biology, 2025, in pressDOI (Open Access)
-
Transcription factor switching drives subtype-specific pancreatic cancerIn: Nature Genetics, Vol. 57, 2025, Nr. 12, pp. 3016 – 3026DOI (Open Access)
-
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancerIn: Nature Communications, Vol. 16, 2025, Nr. 1, 10983DOI (Open Access)
-
Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective nicheIn: Cancer Cell, 2025, in pressDOI (Open Access)
-
ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chainsIn: The EMBO Journal, Vol. 44, 2025, Nr. 18, pp. 5086 – 5111DOI (Open Access)
-
Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response SignalingIn: Cancer Discovery, Vol. 15, 2025, Nr. 12, pp. 2437 – 2449DOI, Online Full Text (Open Access)
-
Günter Wulff (1935 –2023) : Father of Molecular ImprintingIn: Angewandte Chemie International Edition, Vol. 63, 2024, Nr. 12, e202402244DOI (Open Access)
-
TopBP1 utilises a bipartite GINS binding mode to support genome replicationIn: Nature Communications, Vol. 15, 2024, Nr. 1, 1797DOI, Online Full Text (Open Access)
-
Structure of the human KMN complex and implications for regulation of its assemblyIn: Nature Structural & Molecular Biology, Vol. 31, 2024, Nr. 6, pp. 861 – 873DOI (Open Access)
-
Evolutionary trajectories of small cell lung cancer under therapyIn: Nature, Vol. 627, 2024, Nr. 8005, pp. 880 – 889DOI (Open Access)
-
VCF1 is a p97/VCP cofactor promoting recognition of ubiquitylated p97-UFD1-NPL4 substratesIn: Nature Communications, Vol. 15, 2024, Nr. 1, 2459DOI (Open Access)
-
The journey to understand previously unknown microbial genesIn: Nature, Vol. 626, 2024, Nr. 7998, pp. 267 – 269
-
A validation strategy to assess the role of phase separation as a determinant of macromolecular localizationIn: Molecular Cell, Vol. 84, 2024, Nr. 9, pp. 1783 – 1801.e7DOI (Open Access)
-
T antigen–specific CD8⁺ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinomaIn: The Journal of Clinical Investigation (JCI), Vol. 134, 2024, Nr. 8, e177082DOI (Open Access)
-
De novo and salvage purine synthesis pathways across tissues and tumorsIn: Cell, Vol. 187, 2024, Nr. 14, pp. 3602 – 3618.e20
-
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaIn: The New England Journal of Medicine, Vol. 7, 2024, Nr. 391, pp. 1709 – 1720
-
Ripretinib versus sunitinib in gastrointestinal stromal tumor : ctDNA biomarker analysis of the phase 3 INTRIGUE trialIn: Nature Medicine, Vol. 30, 2024, Nr. 2, pp. 498 – 506DOI (Open Access)
-
Subtilase SBT5.2 inactivates flagellin immunogenicity in the plant apoplastIn: Nature Communications, Vol. 15, 2024, Nr. 1, 10431DOI (Open Access)
-
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancerIn: Nature Communications, Vol. 15, 2024, Nr. 1, 10534DOI (Open Access)
-
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaIn: Science Advances, Vol. 10, 2024, Nr. 48, eadp4670DOI (Open Access)
-
A global comparison of surface and subsurface microbiomes reveals large-scale biodiversity gradients, and a marine-terrestrial divideIn: Science Advances, Vol. 10, 2024, Nr. 51, eadq0645DOI (Open Access)
-
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialIn: Lancet, Vol. 403, 2024, Nr. 10445, pp. 2709 – 2719
-
T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vesselsIn: Immunity, Vol. 57, 2024, Nr. 11, pp. 2688 – 2703.e11DOI (Open Access)
-
Regulation of minimal spindle midzone organization by mitotic kinasesIn: Nature Communications, Vol. 15, 2024, Nr. 1, 9213DOI (Open Access)
-
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophyIn: Acta Neuropathologica, Vol. 147, 2024, Nr. 1, 53DOI (Open Access)
-
Lysosomal damage sensing and lysophagy initiation by SPG20-ITCHIn: Molecular Cell, 2024, pp. 1556 – 1569.e10DOI, Online Full Text (Open Access)
-
An atlas of cells in the human tonsilIn: Immunity, Vol. 57, 2024, Nr. 2, pp. 379 – 399.e18DOI (Open Access)
-
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer : A randomized phase 2 trialIn: Nature Medicine, Vol. 30, 2024, Nr. 6, pp. 1602 – 1611DOI (Open Access)
-
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAIn: Blood, Vol. 143, 2024, Nr. 6, pp. 522 – 534
-
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanomaIn: Cell, Vol. 187, 2024, Nr. 1, pp. 166 – 183.e25DOI (Open Access)
-
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRAIn: Nature Communications, Vol. 15, 2024, Nr. 1, 63DOI (Open Access)
-
XPO1-Mediated mRNA Export of Genome Maintenance Regulators Drives Chemotherapy Resistance in Aggressive LymphomaIn: Cancer Research, Vol. 84, 2024, Nr. 1, pp. 3 – 5
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease : a secondary analysis from MARIPOSAIn: Annals of Oncology, Vol. 35, 2024, Nr. 9, pp. 805 – 816DOI (Open Access)
-
Rational correction of pathogenic conformational defects in HTRA1In: Nature Communications, Vol. 15, 2024, Nr. 1, 5944DOI (Open Access)
-
Cranioencephalic functional lymphoid units in glioblastomaIn: Nature Medicine, Vol. 30, 2024, Nr. 10, pp. 2947 – 2956DOI (Open Access)
-
A modular DNA origami nanocompartment for engineering a cell-free, protein unfolding and degradation pathwayIn: Nature Nanotechnology, Vol. 19, 2024, Nr. 10, pp. 1521 – 1531DOI (Open Access)
-
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatmentIn: Nature Communications, Vol. 15, 2024, Nr. 1, 4120DOI (Open Access)
-
Microtubule end-on attachment maturation regulates Mps1 association with its kinetochore receptorIn: Current Biology, Vol. 34, 2024, Nr. 11, pp. 2279 – 2293.e6DOI (Open Access)
-
iSERS : From nanotag design to protein assays and ex vivo imagingIn: Chemical Society Reviews, Vol. 53, 2024, Nr. 13, pp. 6675 – 6693DOI (Open Access)
-
Short-term post-fast refeeding enhances intestinal stemness via polyaminesIn: Nature, Vol. 633, 2024, Nr. 8031, pp. 895 – 904DOI, Online Full Text (Open Access)
-
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer : A multicentre retrospective studyIn: The Lancet Oncology, Vol. 25, 2024, Nr. 9, pp. 1188 – 1201DOI (Open Access)
-
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDSIn: Blood, Vol. 144, 2024, Nr. 16, pp. 1747 – 1751
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : Long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology, Vol. 25, 2024, Nr. 9, pp. 1202 – 1212
-
Cardiac wasting and cancerIn: European Heart Journal, Vol. 45, 2024, Nr. 34, pp. 3135 – 3137DOI (Open Access)
-
BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathwayIn: Science Advances, Vol. 10, 2024, Nr. 36, eadn9361DOI (Open Access)
-
Role of protein kinase PLK1 in the epigenetic maintenance of centromeresIn: Science, Vol. 385, 2024, Nr. 6713, pp. 1091 – 1097
-
Thirty years of structural changesIn: Nature Structural & Molecular Biology, Vol. 31, 2024, Nr. 1, pp. 4 – 5
-
[¹⁷⁷Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2) : an open-label, randomised, phase 3 studyIn: Lancet, Vol. 403, 2024, Nr. 10446, pp. 2807 – 2817
-
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors : A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 StudiesIn: Clinical Cancer Research, Vol. 30, 2024, Nr. 4, pp. 719 – 728
-
Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesisIn: Science, Vol. 386, 2024, Nr. 6722, eado6836
-
Structure-based discovery of first inhibitors targeting the helicase activity of human PIF1In: Nucleic Acids Research, Vol. 52, 2024, Nr. 20, pp. 12616 – 12632DOI (Open Access)
-
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasisIn: Science Advances, Vol. 10, 2024, Nr. 44, eadk8801DOI (Open Access)
-
Visualizing Active Sites in Electrospun Photoactive Membranes via Fluorescence Lifetime ImagingIn: Angewandte Chemie International Edition, Vol. 63, 2024, Nr. 50, e202414412DOI (Open Access)
-
¹⁷⁷Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore) : A phase 3, randomised, controlled trialIn: Lancet, Vol. 404, 2024, Nr. 10459, pp. 1227 – 1239
-
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationIn: The New England Journal of Medicine, Vol. 391, 2024, Nr. 19, pp. 1799 – 1809
-
Novel 3D-ECG algorithms for reliable screening of cardiac amyloidosisIn: European Heart Journal, Vol. 45, 2024, Nr. Supplement_1, ehae6663428
-
Phalloidin and DNase I-bound F-actin pointed end structures reveal principles of filament stabilization and disassemblyIn: Nature Communications, Vol. 15, 2024, Nr. 1, 7969DOI (Open Access)
-
Molecular mechanism of actin filament elongation by forminsIn: Science, Vol. 384, 2024, Nr. 6692
-
Routine extracorporeal life support in infarct-related cardiogenic shock : 1-year results of the ECLS-SHOCK trialIn: European Heart Journal, Vol. 45, 2024, Nr. 39, pp. 4200 – 4203DOI (Open Access)
-
Comparison of pulsed field ablation versus cryoballon and radiofrequency ablation for pulmonary vein isolation in atrial fibrillation patients with heart failureIn: European Heart Journal, Vol. 45, 2024, Nr. Supplement_1, ehae666.578DOI (Open Access)
-
Tuning Nanobodies’ Bioactivity : Coupling to Ultrasmall Gold Nanoparticles Allows the Intracellular Interference with SurvivinIn: Small, Vol. 19, 2023, Nr. 33, 2300871 , 10.1002/smll.202300871DOI (Open Access)
-
Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial TherapyIn: Cancer Research, Vol. 83, 2023, Nr. 8, pp. 1315 – 1328DOI (Open Access)
-
Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain ColonizationIn: Cancer Research, Vol. 83, 2023, Nr. 8, pp. 1299 – 1314DOI (Open Access)
-
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancerIn: Gut, Vol. 72, 2023, Nr. 6, pp. 1174 – 1185DOI, Online Full Text (Open Access)
-
Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesisIn: Nature Communications, Vol. 14, 2023, Nr. 1, 2275DOI (Open Access)
-
The transcriptional and regulatory identity of erythropoietin producing cellsIn: Nature Medicine, Vol. 29, 2023, Nr. 5, pp. 1191 – 1200
-
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationIn: Blood, Vol. 141, 2023, Nr. 23, pp. 2901 – 2911DOI (Open Access)
-
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma : An international collaborative analysisIn: Leukemia, Vol. 37, 2023, Nr. 7, pp. 1511 – 1520DOI (Open Access)
-
Tuning the Electronic Properties of Platinum in Hybrid-Nanoparticle Assemblies for use in Hydrogen Evolution ReactionIn: Angewandte Chemie International Edition, Vol. 62, 2023, Nr. 25, e202301065DOI (Open Access)
-
Neoadjuvant immunotherapy for melanoma is now ready for clinical practiceIn: Nature Medicine, Vol. 29, 2023, Nr. 6, pp. 1310 – 1312
-
HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistanceIn: Clinical Cancer Research, Vol. 29, 2023, Nr. 15, pp. 2894 – 2907
-
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsIn: Science, Vol. 380, 2023, Nr. 6640, pp. 93 – 101DOI, Online Full Text (Open Access)
-
The UBX domain in UBXD1 organizes ubiquitin binding at the C-terminus of the VCP/p97 AAA-ATPaseIn: Nature Communications, Vol. 14, 2023, Nr. 1, 3258DOI, Online Full Text (Open Access)
-
Importance of broken geometric symmetry of single-atom Pt sites for efficient electrocatalysisIn: Nature Communications, Vol. 14, 2023, Nr. 1, 3233DOI (Open Access)
-
The landscape of viral associations in human cancersIn: Nature Genetics, 2023, Nr. 52, pp. 320 – 330DOI (Open Access)
-
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O) : disease-free survival results from a randomised, open-label, phase 2 trialIn: Lancet, Vol. 402, 2023, Nr. 10404, pp. 798 – 808
-
Resting natural killer cell homeostasis relies on tryptophan/NAD⁺ metabolism and HIF-1αIn: EMBO Reports, 2023, e56156DOI (Open Access)
-
Clp-targeting BacPROTACs impair mycobacterial proteostasis and survivalIn: Cell, Vol. 186, 2023, Nr. 10, pp. 2176 – 2192.e22DOI (Open Access)
-
Circulating tumor DNA analysis of the phase III VOYAGER trial : KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenibIn: Annals of Oncology, Vol. 34, 2023, Nr. 7, pp. 615 – 625DOI, Online Full Text (Open Access)
-
Stable kinetochore-microtubule attachment requires loop-dependent Ndc80-Ndc80 bindingIn: The EMBO Journal, Vol. 42, 2023, Nr. 13, e112504DOI (Open Access)
-
Structural basis of ubiquitin-independent PP1 complex disassembly by p97In: The EMBO Journal, Vol. 42, 2023, Nr. 14, e113110DOI (Open Access)
-
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunityIn: Cancer Cell, Vol. 41, 2023, Nr. 7, pp. 1207 – 1221.e12DOI (Open Access)
-
Health-related quality of life and pain outcomes with [¹⁷⁷Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION) : a multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology, Vol. 24, 2023, Nr. 6, pp. 597 – 610
-
Chirality control of a single carbene molecule by tip-induced van der Waals interactionsIn: Nature Communications, Vol. 14, 2023, Nr. 1, 4500DOI (Open Access)
-
The German Network for Personalized Medicine to enhance patient care and translational researchIn: Nature Medicine, Vol. 29, 2023, Nr. 6, pp. 1298 – 1301
-
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progressionIn: Neuro-Oncology, Vol. 25, 2023, Nr. 12, pp. 2150 – 2162DOI, Online Full Text (Open Access)
-
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationIn: Nature Communications, Vol. 14, 2023, Nr. 1, 4632DOI (Open Access)
-
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR) : An international, single-arm, phase 2 studyIn: The Lancet Oncology, Vol. 24, 2023, Nr. 8, pp. 925 – 935
-
Impact of bimetallic interface design on heat generation in plasmonic Au/Pd nanostructures studied by single-particle thermometryIn: Nature Communications, Vol. 14, 2023, Nr. 1, 3813DOI (Open Access)
-
Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infectionIn: Science Advances, Vol. 9, 2023, Nr. 27, eadf8251DOI (Open Access)
-
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsIn: The Journal of Clinical Investigation (JCI), Vol. 133, 2023, Nr. 12, e163548DOI (Open Access)
-
Extracorporeal Life Support in Infarct-Related Cardiogenic ShockIn: The New England Journal of Medicine, Vol. 389, 2023, Nr. 14, pp. 1286 – 1297
-
Marine viruses disperse bidirectionally along the natural water cycleIn: Nature Communications, Vol. 14, 2023, Nr. 1, 6354DOI, Online Full Text (Open Access)
-
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerIn: Nature Genetics, Vol. 52, 2023, Nr. 3, pp. 294 – 305DOI (Open Access)
-
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG¹²C mutation : a randomised, open-label, phase 3 trialIn: Lancet, Vol. 401, 2023, Nr. 10378, pp. 733 – 746DOI, Online Full Text (Open Access)
-
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerIn: Nature, Vol. 615, 2023, Nr. 7950, pp. 168 – 174DOI (Open Access)
-
Photomechanical Laser Fragmentation of IrO₂ Microparticles for the Synthesis of Active and Redox-Sensitive Colloidal NanoclustersIn: Small, Vol. 19, 2023, Nr. 10, 2206485DOI (Open Access)
-
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer GrowthIn: Clinical Cancer Research, Vol. 29, 2023, Nr. 6, pp. 1137 – 1154
-
Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotypeIn: Gut, Vol. 72, 2023, Nr. 3, pp. 522 – 534DOI (Open Access)
-
Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophyIn: Acta Neuropathologica, Vol. 145, 2023, Nr. 5, pp. 611 – 635DOI (Open Access)
-
Differentiating between Acidic and Basic Surface Hydroxyls on Metal Oxides by Fluoride Substitution : A Case Study on Blue TiO₂ from Laser Defect EngineeringIn: Angewandte Chemie International Edition, Vol. 62, 2023, Nr. 12, e202213968DOI (Open Access)
-
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaIn: Clinical Cancer Research, Vol. 29, 2023, Nr. 2, pp. 488 – 500DOI (Open Access)
-
The structural flexibility of MAD1 facilitates the assembly of the Mitotic Checkpoint ComplexIn: Nature Communications, Vol. 14, 2023, Nr. 1, 1529DOI (Open Access)
-
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic CancerIn: The New England Journal of Medicine, Vol. 388, 2023, Nr. 1, pp. 33 – 43DOI (Open Access)
-
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasIn: Cancer Cell, Vol. 41, 2023, Nr. 1, pp. 210 – 225.e5DOI (Open Access)
-
Immunotherapy targeting plasma ASM is protective in a mouse model of Alzheimer’s diseaseIn: Nature Communications, Vol. 14, 2023, Nr. 1, 1631DOI (Open Access)
-
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerIn: The Journal of Clinical Investigation (JCI), Vol. 133, 2023, Nr. 21, e174171DOI (Open Access)
-
ComplexEye : a multi-lens array microscope for high-throughput embedded immune cell migration analysisIn: Nature Communications, Vol. 14, 2023, Nr. 1, 8103DOI, Online Full Text (Open Access)
-
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 TrialIn: Clinical Cancer Research, Vol. 29, 2023, Nr. 24, pp. 5057 – 5068
-
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomasIn: Neuro-Oncology, Vol. 25, 2023, Nr. 9, pp. 1721 – 1723DOI (Open Access)
-
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesIn: Immunity, Vol. 56, 2023, Nr. 6, pp. 1341 – 1358.e11DOI (Open Access)
-
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphomaIn: Blood, Vol. 141, 2023, Nr. 25, pp. 3055 – 3064DOI (Open Access)
-
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaIn: Acta Neuropathologica, Vol. 149, 2023, Nr. 4, pp. 551 – 564DOI (Open Access)
-
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patientsIn: Nature Communications, Vol. 14, 2023, Nr. 1, 2835DOI (Open Access)
-
Structure of the peroxisomal Pex1/Pex6 ATPase complex bound to a substrateIn: Nature Communications, Vol. 14, 2023, Nr. 1, 5942DOI (Open Access)
-
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingIn: Nature Genetics, Vol. 52, 2023, pp. 331 – 341DOI (Open Access)
-
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialIn: Clinical Cancer Research, Vol. 29, 2023, Nr. 17, pp. 3313 – 3319DOI (Open Access)
-
The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality : systematic review and individual participant data meta-analysisIn: The Lancet Diabetes and Endocrinology, Vol. 11, 2023, Nr. 10, pp. 743 – 754DOI, Online Full Text (Open Access)
-
Dynamics and durability of HIV-1 neutralization are determined by viral replicationIn: Nature Medicine, Vol. 29, 2023, Nr. 11, pp. 2763 – 2774DOI (Open Access)
-
RZZ‐Spindly and CENP‐E form an integrated platform to recruit dynein to the kinetochore coronaIn: The EMBO Journal, Vol. 42, 2023, Nr. 24, e114838DOI (Open Access)
-
The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latencyIn: Cell Reports, Vol. 42, 2023, Nr. 11, 113285DOI (Open Access)
-
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyIn: Blood, Vol. 142, 2023, Nr. 25, pp. 2175 – 2191DOI (Open Access)
-
Transcriptional reprogramming by mutated IRF4 in lymphomaIn: Nature Communications, Vol. 14, 2023, Nr. 1, 6947DOI (Open Access)
-
Data-driven grading of acute graft-versus-host diseaseIn: Nature Communications, Vol. 14, 2023, Nr. 1, 7799DOI, Online Full Text (Open Access)
-
Leptin receptor⁺ cells promote bone marrow innervation and regeneration by synthesizing nerve growth factorIn: Nature Cell Biology, Vol. 25, 2023, Nr. 12, pp. 1746 – 1757DOI (Open Access)
-
Optimizing platelet transfusion through a personalized deep learning risk assessment system for demand managementIn: Blood, Vol. 142, 2023, Nr. 26, pp. 2315 – 2326
-
Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma : follow-up and survival outcomes of a single-arm, multicentre, phase 2 studyIn: The Lancet Oncology, Vol. 24, 2023, Nr. 11, pp. 1196 – 1205
-
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and PentamerIn: Immunity, Vol. 56, 2023, Nr. 11, pp. 2602 – 2620.e10
-
Rho GTPase activity crosstalk mediated by Arhgef11 and Arhgef12 coordinates cell protrusion-retraction cyclesIn: Nature Communications, Vol. 14, 2023, Nr. 1, 8356DOI (Open Access)
-
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcriptionIn: Science Advances, Vol. 9, 2023, Nr. 41, eadg5109DOI (Open Access)
-
Genomic basis for RNA alterations in cancerIn: Nature, Vol. 578, 2023, Nr. 7793, pp. 129 – 136DOI (Open Access)
-
Patterns of somatic structural variation in human cancer genomesIn: Nature, Vol. 578, 2023, Nr. 7793, pp. 112 – 121DOI (Open Access)
-
Analyses of non-coding somatic drivers in 2,658 cancer whole genomesIn: Nature, Vol. 578, 2023, Nr. 7793, pp. 102 – 111DOI (Open Access)
-
The repertoire of mutational signatures in human cancerIn: Nature, Vol. 578, 2023, Nr. 7793, pp. 94 – 101DOI (Open Access)
-
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid CancerIn: The New England Journal of Medicine, Vol. 389, 2023, Nr. 20, pp. 1851 – 1861
-
Structure and activation mechanism of the Makes caterpillars floppy 1 toxinIn: Nature Communications, Vol. 14, 2023, Nr. 1, 8226DOI (Open Access)
-
Structure of the native myosin filament in the relaxed cardiac sarcomereIn: Nature, Vol. 623, 2023, Nr. 7988, pp. 863 – 871DOI (Open Access)
-
Molecular mechanisms of inorganic-phosphate release from the core and barbed end of actin filamentsIn: Nature Structural & Molecular Biology, Vol. 30, 2023, Nr. 11, pp. 1774 – 1785DOI (Open Access)
-
TomoTwin : generalized 3D localization of macromolecules in cryo-electron tomograms with structural data miningIn: Nature Methods, Vol. 20, 2023, Nr. 6, pp. 871 – 880DOI (Open Access)
-
Structural basis of mRNA binding by the human FERRY Rab5 effector complexIn: Molecular Cell, Vol. 83, 2023, Nr. 11, pp. 1856 – 1871.e9DOI (Open Access)
-
The role of DNA nanostructures in the catalytic properties of an allosterically regulated proteaseIn: Science Advances, Vol. 8, 2022, Nr. 1, abk0425DOI (Open Access)
-
Preneoplastic somatic mutations including MYD88L²⁶⁵P in lymphoplasmacytic lymphomaIn: Science Advances, Vol. 8, 2022, Nr. 3, eabl4644DOI (Open Access)
-
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaIn: Blood, Vol. 139, 2022, Nr. 4, pp. 538 – 553DOI (Open Access)
-
Cellular plasticity upon proton irradiation determines tumor cell radiosensitivityIn: Cell Reports, Vol. 38, 2022, Nr. 8, 110422DOI (Open Access)
-
Stroke induces disease-specific myeloid cells in the brain parenchyma and piaIn: Nature Communications, Vol. 13, 2022, Nr. 1, 945DOI (Open Access)
-
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationIn: Clinical Cancer Research, Vol. 28, 2022, Nr. 5, pp. 1004 – 1012DOI (Open Access)
-
Structure of the RZZ complex and molecular basis of Spindly‐driven corona assembly at human kinetochoresIn: The EMBO Journal, Vol. 41, 2022, Nr. 9, e110411DOI, Online Full Text (Open Access)
-
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma : Interim analysis of the GMMG-CONCEPT trialIn: Leukemia, Vol. 36, 2022, Nr. 3, pp. 885 – 888DOI (Open Access)
-
Enhancement of Proton Therapy Efficiency by Noble Metal Nanoparticles Is Driven by the Number and Chemical Activity of Surface AtomsIn: Small, Vol. 18, 2022, Nr. 9, 2106383DOI (Open Access)
-
Gastrointestinal stromal tumours : ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology, Vol. 33, 2022, Nr. 1, pp. 20 – 33DOI (Open Access)
-
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced MelanomaIn: The New England Journal of Medicine, Vol. 386, 2022, Nr. 1, pp. 24 – 34DOI, Online Full Text (Open Access)
-
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor MicroenvironmentIn: Cancer Research, Vol. 82, 2022, Nr. 2, pp. 264 – 277DOI (Open Access)
-
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expressionIn: Nature Communications, Vol. 13, 2022, Nr. 1, 156DOI (Open Access)
-
DJ-1 depletion prevents immunoaging in T-cell compartmentsIn: EMBO Reports, Vol. 23, 2022, Nr. 3, e53302DOI (Open Access)
-
On the role of phase separation in the biogenesis of membraneless compartmentsIn: The EMBO Journal, Vol. 41, 2022, Nr. 5, e109952DOI (Open Access)
-
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyIn: European Heart Journal, Vol. 43, 2022, Nr. 4, pp. 316 – 329
-
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignanciesIn: Blood, Vol. 140, 2022, Nr. 20, pp. 2113 – 2126DOI (Open Access)
-
Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathwayIn: Nature Communications, Vol. 13, 2022, Nr. 1, 2698DOI (Open Access)
-
Gold Nanorods Induce Endoplasmic Reticulum Stress and Autocrine Inflammatory Activation in Human NeutrophilsIn: ACS Nano, Vol. 16, 2022, Nr. 7, pp. 11011 – 11026
-
3D structure and in situ arrangements of CatSper channel in the sperm flagellumIn: Nature Communications, Vol. 13, 2022, Nr. 1, 3439DOI (Open Access)
-
BacPROTACs mediate targeted protein degradation in bacteriaIn: Cell, Vol. 185, 2022, Nr. 13, pp. 2338 – 2353.e18DOI (Open Access)
-
Ubiquitin profiling of lysophagy identifies actin stabilizer CNN2 as a target of VCP/p97 and uncovers a link to HSPB1In: Molecular Cell, Vol. 82, 2022, Nr. 14, pp. 2633 – 2649.e7DOI (Open Access)
-
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trialIn: Nature Medicine, Vol. 28, 2022, Nr. 8, pp. 1640 – 1645DOI (Open Access)
-
During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodesIn: Cell Reports, Vol. 40, 2022, Nr. 7, 111171DOI (Open Access)
-
Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone massIn: eLife, Vol. 8, 2022, pp. e42274DOI (Open Access)
-
MCU controls melanoma progression through a redox-controlled phenotype switchIn: EMBO Reports, Vol. 23, 2022, Nr. 11, e54746DOI (Open Access)
-
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesIn: Clinical Cancer Research, Vol. 28, 2022, Nr. 19, pp. 4346 – 4353DOI (Open Access)
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research, Vol. 28, 2022, Nr. 19, pp. 4194 – 4202DOI (Open Access)
-
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : Final results of a randomised, double-blind, phase 2 trialIn: Lancet, Vol. 400, 2022, Nr. 10358, pp. 1117 – 1129
-
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)In: Annals of Oncology, Vol. 33, 2022, Nr. 6, pp. 602 – 615DOI (Open Access)
-
Persister state-directed transitioning and vulnerability in melanoma
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Nature Communications, Vol. 13, 2022, Nr. 1, pp. 35 – 36DOI, Online Full Text (Open Access) -
Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell ModelsIn: Small, 2022, 2201167DOI (Open Access)
-
A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantationIn: Blood, Vol. 140, 2022, Nr. 6, pp. 659 – 663DOI (Open Access)
-
C11orf94/Frey is a key regulator for male fertility by controlling Izumo1 complex assemblyIn: Science Advances, Vol. 8, 2022, Nr. 32, eabo6049DOI (Open Access)
-
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT) : the prospective multicentre phase II PTLD-2 trialIn: Leukemia, Vol. 36, 2022, Nr. 10, pp. 2468 – 2478DOI (Open Access)
-
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma : Results from a Proof-of-Concept, Phase Ib StudyIn: Clinical Cancer Research, Vol. 28, 2022, Nr. 6, pp. 1087 – 1097DOI (Open Access)
-
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19In: Nature, Vol. 609, 2022, Nr. 7928, pp. 801 – 807DOI, Online Full Text (Open Access)
-
The RUHR Heart Failure Network : Improved heart failure care in a metropolitan areaIn: European Heart Journal, Vol. 43, 2022, Nr. 45, pp. 4675 – 4676DOI (Open Access)
-
The acid ceramidase/ceramide axis controls parasitemia in Plasmodium yoelii-infected mice by regulating erythropoiesisIn: eLife, Vol. 11, 2022, e77975DOI, Online Full Text (Open Access)
-
Surface Diffusion Aided by a Chirality Change of Self-Assembled Oligomers under 2D ConfinementIn: Angewandte Chemie International Edition, Vol. 61, 2022, Nr. 43, e202212245DOI (Open Access)
-
CTLA-4 Blockade Resistance after Relatlimab and NivolumabIn: The New England Journal of Medicine, Vol. 386, 2022, Nr. 17, pp. 1668 – 1669DOI (Open Access)
-
The alarmin interleukin-1α triggers secondary degeneration through reactive astrocytes and endothelium after spinal cord injuryIn: Nature Communications, Vol. 13, 2022, Nr. 1, 5786DOI (Open Access)
-
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716) : distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trialIn: The Lancet Oncology, Vol. 23, 2022, Nr. 11, pp. 1378 – 1388
-
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trialIn: Lancet, Vol. 399, 2022, Nr. 10336, pp. 1718 – 1729
-
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsIn: Nature Communications, Vol. 13, 2022, Nr. 1, 4061DOI (Open Access)
-
Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repairIn: EMBO Reports, Vol. 23, 2022, Nr. 10, e54136DOI (Open Access)
-
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant MelanomaIn: Clinical Cancer Research, Vol. 28, 2022, Nr. 14, pp. 3002 – 3010DOI (Open Access)
-
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesIn: Blood, Vol. 139, 2022, Nr. 25, pp. 3617 – 3629DOI (Open Access)
-
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphomaIn: Blood, Vol. 140, 2022, Nr. 10, pp. 1119 – 1131DOI (Open Access)
-
The TRESLIN-MTBP complex couples completion of DNA replication with S/G2 transitionIn: Molecular Cell, Vol. 82, 2022, Nr. 18, pp. 3350 – 3365.e7DOI (Open Access)
-
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell CarcinomaIn: The New England Journal of Medicine, Vol. 387, 2022, Nr. 17, pp. 1557 – 1568DOI, Online Full Text (Open Access)
-
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trialIn: Leukemia, Vol. 36, 2022, Nr. 12, pp. 2845 – 2852DOI (Open Access)
-
Chemoproteomics‐Enabled Identification of 4‐Oxo‐β‐Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9In: Angewandte Chemie International Edition, Vol. 61, 2022, Nr. 47, e202210498DOI (Open Access)
-
Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality : Results from 49,089 COVID-19 inpatientsIn: Molecular Psychiatry, Vol. 27, 2022, Nr. 3, pp. 1278 – 1280DOI (Open Access)
-
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute LeukemiaIn: Clinical Cancer Research, Vol. 28, 2022, Nr. 5, pp. 870 – 881DOI (Open Access)
-
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations : Results from a Multi-institutional European Retrospective StudyIn: Clinical Cancer Research, Vol. 28, 2022, Nr. 8, pp. 1672 – 1679DOI (Open Access)
-
Compartmentalized metabolism supports midgestation mammalian developmentIn: Nature, Vol. 604, 2022, Nr. 7905, pp. 349 – 353DOI (Open Access)
-
ACKR3 regulates platelet activation and ischemia-reperfusion tissue injuryIn: Nature Communications, Vol. 13, 2022, Nr. 1, 1823DOI (Open Access)
-
Structure of the human inner kinetochore CCAN complex and its significance for human centromere organizationIn: Molecular Cell, Vol. 82, 2022, Nr. 11, pp. 2113 – 2131.e8DOI (Open Access)
-
Mapping the Regioisomeric Space and Visible Color Range of Purely Organic Dual Emitters with Ultralong Phosphorescence Components : From Violet to Red Towards Pure White LightIn: Angewandte Chemie International Edition, Vol. 61, 2022, Nr. 4, e202111805DOI (Open Access)
-
Particle Size-Dependent Onset of the Tunneling Regime in Ideal Dimers of Gold NanospheresIn: ACS Nano, Vol. 16, 2022, Nr. 12, pp. 21377 – 21387
-
B cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healingIn: Immunity, Vol. 55, 2022, Nr. 12, pp. 2336 – 2351.e12DOI (Open Access)
-
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersIn: Annals of Oncology, Vol. 33, 2022, Nr. 11, pp. 1186 – 1199DOI (Open Access)
-
Cell-intrinsic ceramides determine T cell function during melanoma progressionIn: eLife, Vol. 11, 2022, e83073DOI (Open Access)
-
In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumorsIn: Science Advances, Vol. 8, 2022, Nr. 35, eabn9550DOI (Open Access)
-
Stroke genetics informs drug discovery and risk prediction across ancestriesIn: Nature, Vol. 611, 2022, Nr. 7934, pp. 115 – 123DOI (Open Access)
-
Mechanism of threonine ADP-ribosylation of F-actin by a Tc toxinIn: Nature Communications, Vol. 13, 2022, Nr. 1, 4202
-
Structural basis of actin filament assembly and agingIn: Nature, Vol. 611, 2022, Nr. 7935, pp. 374 – 379DOI (Open Access)
-
Structures from intact myofibrils reveal mechanism of thin filament regulation through nebulinIn: Science, Vol. 375, 2022, Nr. 6582, eabn1934DOI, Online Full Text (Open Access)
-
CRISPR screens in Drosophila cells identify Vsg as a Tc toxin receptorIn: Nature, Vol. 610, 2022, Nr. 7931, pp. 349 – 355DOI, Online Full Text (Open Access)
-
A cryogenic, coincident fluorescence, electron, and ion beam microscopeIn: eLife, Vol. 11, 2022, e82891DOI (Open Access)
-
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemiaIn: Leukemia, Vol. 35, 2021, Nr. 2, pp. 585 – 594
-
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW) : a multi-cohort, open-label, registrational, phase 1/2 studyIn: The Lancet Diabetes and Endocrinology, Vol. 9, 2021, Nr. 8, pp. 491 – 501
-
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus TrametinibIn: Clinical Cancer Research, Vol. 27, 2021, Nr. 16, pp. 4500 – 4510DOI (Open Access)
-
Cellular model system to dissect the isoform-selectivity of Akt inhibitorsIn: Nature Communications, Vol. 12, 2021, Nr. 1, 5297DOI (Open Access)
-
Metabolic requirements of NK cells during the acute response against retroviral infectionIn: Nature Communications, Vol. 12, 2021, Nr. 1, 5376DOI, Online Full Text (Open Access)
-
Coating of cochlear implant electrodes with bioactive DNA-loaded calcium phosphate nanoparticles for the local transfection of stimulatory proteinsIn: Biomaterials, Vol. 276, 2021
-
Phospho-regulated Bim1/EB1 interactions trigger Dam1c ring assembly at the budding yeast outer kinetochoreIn: The EMBO Journal, Vol. 40, 2021, Nr. 18, e108004DOI (Open Access)
-
Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective studyIn: The Lancet Oncology, Vol. 22, 2021, Nr. 8, pp. 1115 – 1125DOI (Open Access)
-
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-IIn: Nature Communications, Vol. 12, 2021, Nr. 1, 5505DOI (Open Access)
-
Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging TrialIn: JAMA Oncology, Vol. 7, 2021, Nr. 11, pp. 1635 – 1642
-
Multiple Hepatic and Pulmonary Tumors Combined with Bilateral Adrenal Masses in a Young Woman with von Hippel–Lindau DiseaseIn: Gastroenterology, Vol. 161, 2021, Nr. 4, pp. e1 – e4DOI (Open Access)
-
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defectsIn: Molecular Psychiatry, Vol. 26, 2021, Nr. 12, pp. 7403 – 7416DOI (Open Access)
-
PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected miceIn: EMBO Reports, 2021, e53007DOI (Open Access)
-
Nuclear medicine theranostics comes of ageIn: The Lancet Oncology, Vol. 22, 2021, Nr. 11, pp. 1497 – 1498
-
Protein Signatures of NK Cell–Mediated Melanoma Killing Predict Response to ImmunotherapiesIn: Cancer Research, Vol. 81, 2021, Nr. 21, pp. 5540 – 5554DOI, Online Full Text (Open Access)
-
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumoursIn: Annals of Oncology, Vol. 32, 2021, Nr. 11, pp. 1332 – 1347DOI (Open Access)
-
Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasisIn: Cell Reports, Vol. 37, 2021, Nr. 8, 110056DOI, Online Full Text (Open Access)
-
Targeted substrate loop insertion by VCP/p97 during PP1 complex disassemblyIn: Nature Structural & Molecular Biology, Vol. 28, 2021, Nr. 12, pp. 964 – 971
-
Bone sarcomas : ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-upIn: Annals of Oncology, Vol. 32, 2021, Nr. 12, pp. 1520 – 1536DOI (Open Access)
-
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS StudyIn: Clinical Cancer Research, Vol. 27, 2021, Nr. 23, pp. 6333 – 6342DOI, Online Full Text (Open Access)
-
Mapping the human genetic architecture of COVID-19In: Nature, Vol. 600, 2021, Nr. 7889, pp. 472 – 477DOI (Open Access)
-
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNAIn: Nature Biotechnology, Vol. 39, 2021, Nr. 12, pp. 1537 – 1547DOI, Online Full Text (Open Access)
-
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19 : Current evidence and potential mechanismsIn: Molecular Psychiatry, Vol. 26, 2021, Nr. 12, pp. 7098 – 7099DOI (Open Access)
-
NK cells in hypoxic skin mediate a trade-off between wound healing and antibacterial defenceIn: Nature Communications, Vol. 12, 2021, Nr. 1, 4700DOI (Open Access)
-
TRIP6 functions in brain ciliogenesisIn: Nature Communications, Vol. 12, 2021, Nr. 1, 5887DOI (Open Access)
-
Sugar-modified B-cell receptors in DLBCLIn: Blood, Vol. 138, 2021, Nr. 17, pp. 1512 – 1514DOI (Open Access)
-
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersIn: Cancer Discovery, Vol. 11, 2021, Nr. 11, pp. 2780 – 2795DOI (Open Access)
-
Soft tissue and visceral sarcomas : ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆In: Annals of Oncology, Vol. 32, 2021, Nr. 11, 1348-1365DOI (Open Access)
-
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesIn: Cancer Discovery, Vol. 2, 2021, Nr. 1, pp. 70 – 91DOI, Online Full Text (Open Access)
-
Cdc4 phospho-degrons allow differential regulation of ame1ceⁿp⁻u protein stability across the cell cycleIn: eLife, Vol. 10, 2021, e67390DOI (Open Access)
-
Nuclear receptor coactivator NCOA3 regulates UV radiation⇓induced DNA damage and melanoma susceptibilityIn: Cancer Research, Vol. 81, 2021, Nr. 11, pp. 2956 – 2969DOI, Online Full Text (Open Access)
-
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasIn: Blood, Vol. 137, 2021, Nr. 20, pp. 2785 – 2799DOI (Open Access)
-
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache : A multicentre, double-blind, randomised controlled trialIn: The Lancet Neurology, Vol. 20, 2021, Nr. 1, pp. 29 – 37
-
BUB1 and CENP-U, Primed by CDK1, Are the Main PLK1 Kinetochore Receptors in MitosisIn: Molecular Cell, Vol. 81, 2021, Nr. 1, pp. 67 – 87.e9DOI (Open Access)
-
CDC20 assists its catalytic incorporation in the mitotic checkpoint complexIn: Science, Vol. 371, 2021, Nr. 6524, pp. 67 – 71
-
Structural basis for the regulation of nucleosome recognition and HDAC activity by histone deacetylase assembliesIn: Science Advances, Vol. 7, 2021, Nr. 2, pp. eabd4413DOI (Open Access)
-
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapyIn: Nature Communications, Vol. 12, 2021, Nr. 1, pp. 346DOI (Open Access)
-
Overlap of NatA and IAP substrates implicates N-terminal acetylation in protein stabilizationIn: Science Advances, Vol. 7, 2021, Nr. 3, pp. eabc8590DOI (Open Access)
-
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113) : a multicentre, randomised, phase 2 trialIn: The Lancet Gastroenterology & Hepatology, Vol. 6, 2021, Nr. 2, pp. 128 – 138
-
Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E StainsIn: Clinical Cancer Research, Vol. 27, 2021, Nr. 4, pp. 1131 – 1138DOI (Open Access)
-
Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatmentIn: Nature Communications, Vol. 12, 2021, Nr. 1, pp. 1707DOI (Open Access)
-
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasionIn: Nature Genetics, Vol. 53, 2021, Nr. 3, pp. 332 – 341DOI (Open Access)
-
New players in the regulation of DNA-PK activity : Survivin joins the crowdIn: Cancer Research, Vol. 81, 2021, Nr. 9, pp. 2270 – 2271DOI (Open Access)
-
FAST : a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinomaIn: Annals of Oncology, Vol. 32, 2021, Nr. 5, pp. 609 – 619DOI (Open Access)
-
Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomasIn: Leukemia, Vol. 35, 2021, pp. 2002 – 2016DOI (Open Access)
-
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal FluidIn: Immunity, Vol. 54, 2021, Nr. 1, pp. 164DOI, Online Full Text (Open Access)
-
Altered mitochondria functionality defines a metastatic cell state in lung cancer and creates an exploitable vulnerabilityIn: Cancer Research, Vol. 81, 2021, Nr. 3, pp. 567 – 579DOI, Online Full Text (Open Access)
-
Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DMIn: Blood, Vol. 137, 2021, Nr. 7, pp. 923 – 928DOI (Open Access)
-
UMI or not UMI, that is the question for scRNA-seq zero-inflationIn: Nature Biotechnology, Vol. 39, 2021, Nr. 2, pp. 158 – 159DOI, Online Full Text (Open Access)
-
Resistance to avapritinib in pdgfra-driven gist is caused by secondary mutations in the pdgfra kinase domainIn: Cancer Discovery, Vol. 11, 2021, Nr. 1, pp. 108 – 125
-
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1In: Blood, Vol. 137, 2021, Nr. 5, pp. 646 – 660DOI (Open Access)
-
Bacterial protein domains with a novel Ig-like fold target human CEACAM receptorsIn: The EMBO Journal, Vol. 40, 2021, Nr. 7, pp. e106103DOI (Open Access)
-
Functional Comparison of Interferon-α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon-α and Interferon-γ SignalingIn: Hepatology, Vol. 73, 2021, Nr. 2, pp. 486 – 502
-
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infectionsIn: Nature Communications, Vol. 12, 2021, Nr. 1, pp. 1112DOI (Open Access)
-
Specific inhibition of the Survivin–CRM1 interaction by peptide-modified molecular tweezersIn: Nature Communications, Vol. 12, 2021, Nr. 1, pp. 1505DOI, Online Full Text (Open Access)
-
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19In: Nature Communications, Vol. 12, 2021, Nr. 1, pp. 1813DOI (Open Access)
-
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infectionIn: Nature Communications, Vol. 12, 2021, Nr. 1, pp. 1726DOI (Open Access)
-
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib : A clinical validation studyIn: The Lancet Oncology, Vol. 22, 2021, Nr. 3, pp. 370 – 380DOI, Online Full Text (Open Access)
-
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman PrimatesIn: Clinical Cancer Research, Vol. 27, 2021, Nr. 7, pp. 2050 – 2060DOI (Open Access)
-
In situ photothermal response of single gold nanoparticles through hyperspectral imaging anti-stokes thermometryIn: ACS Nano, Vol. 15, 2021, Nr. 2, pp. 2458 – 2467DOI, Online Full Text (Open Access)
-
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypesIn: Nature Communications, Vol. 12, 2021, Nr. 1, 2048DOI (Open Access)
-
PI3KC2β inactivation stabilizes VE‐cadherin junctions and preserves vascular integrityIn: EMBO Reports, 2021, pp. e51299DOI, Online Full Text (Open Access)
-
The West German heart and vascular center at university medicine EssenIn: European Heart Journal, Vol. 42, 2021, Nr. 10, pp. 963 – 964DOI (Open Access)
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology, Vol. 22, 2021, Nr. 5, pp. 643 – 654
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology, Vol. 22, 2021, Nr. 5, pp. 655 – 664DOI, Online Full Text (Open Access)
-
Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumorsIn: Clinical Cancer Research, Vol. 27, 2021, Nr. 10, pp. 2723 – 2733DOI (Open Access)
-
Mutations in the IFNγ-JAK-STAT pathway causing resistance to immune checkpoint inhibitors in melanoma increase sensitivity to oncolytic virus treatmentIn: Clinical Cancer Research, Vol. 27, 2021, Nr. 12, pp. 3432 – 3442DOI (Open Access)
-
Single-Particle Hyperspectral Imaging Reveals Kinetics of Silver Ion Leaching from Alloy NanoparticlesIn: ACS Nano, 2021, pp. 8363 – 8375
-
Sotorasib for Lung Cancers with KRAS p.G12C MutationIn: The New England Journal of Medicine, Vol. 384, 2021, Nr. 25, pp. 2371 – 2381DOI, Online Full Text (Open Access)
-
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progressionIn: Nature Communications, Vol. 12, 2021, Nr. 1, 3895DOI (Open Access)
-
Assembly principles and stoichiometry of a complete human kinetochore moduleIn: Science Advances, Vol. 7, 2021, Nr. 27, eabg1037DOI (Open Access)
-
Silica-coated calcium phosphate nanoparticles for gene silencing of NF-κB p65 by siRNA and their impact on cellular players of inflammationIn: Biomaterials, Vol. 276, 2021, pp. 121013
-
Neutrophils self-limit swarming to contain bacterial growth in vivoIn: Science, Vol. 372, 2021, Nr. 6548DOI, Online Full Text (Open Access)
-
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: The New England Journal of Medicine, Vol. 385, 2021, pp. 1091 – 1103DOI, Online Full Text (Open Access)
-
GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancerIn: Cancer Research, Vol. 81, 2021, Nr. 11, pp. 2970 – 2982DOI (Open Access)
-
Molecular architecture of black widow spider neurotoxinsIn: Nature Communications, Vol. 12, 2021, Nr. 1, 6956DOI (Open Access)
-
The molecular basis for sarcomere organization in vertebrate skeletal muscleIn: Cell, Vol. 184, 2021, Nr. 8, pp. 2135 – 2150.e13DOI (Open Access)
-
Cryo-EM Resolves Molecular Recognition Of An Optojasp Photoswitch Bound To Actin Filaments In Both Switch StatesIn: Angewandte Chemie International Edition, Vol. 60, 2021, Nr. 16, pp. 8678 – 8682DOI (Open Access)
-
A barbed end interference mechanism reveals how capping protein promotes nucleation in branched actin networksIn: Nature Communications, Vol. 12, 2021, Nr. 1, 5329DOI (Open Access)
-
Small molecule modulation of the Drosophila Slo channel elucidated by cryo-EMIn: Nature Communications, Vol. 12, 2021, Nr. 1, 7164DOI (Open Access)
-
Structural basis of human separase regulation by securin and CDK1–cyclin B1In: Nature, Vol. 596, 2021, Nr. 7870, pp. 138 – 142DOI, Online Full Text (Open Access)
-
TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulationIn: Molecular Cell, Vol. 81, 2021, Nr. 13, pp. 2705 – 2721.e8DOI (Open Access)
-
Mechanism of actin-dependent activation of nucleotidyl cyclase toxins from bacterial human pathogensIn: Nature Communications, Vol. 12, 2021, Nr. 1, 6628DOI (Open Access)
-
High-resolution structures of the actomyosin-v complex in three nucleotide states provide insights into the force generation mechanismIn: eLife, Vol. 10, 2021, e73724DOI (Open Access)
-
Comprehensive molecular characterization of mitochondrial genomes in human cancersIn: Nature Genetics, Vol. 52, 2020, Nr. 3, pp. 342 – 352DOI (Open Access)
-
Dead Cells Induce Innate Anergy via Mertk after Acute Viral InfectionIn: Cell Reports, Vol. 30, 2020, Nr. 11, pp. 3671 – 3681.e5DOI (Open Access)
-
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 2465DOI (Open Access)
-
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS) : a double-blind, randomised, placebo-controlled, phase 3 trialIn: The Lancet Oncology, Vol. 21, 2020, Nr. 7, pp. 923 – 934DOI, Online Full Text (Open Access)
-
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe diseaseIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 1338DOI, Online Full Text (Open Access)
-
A clinical perspective on the 2019 ESC/EAS guidelines for the management of dyslipidaemias: PCSK-9 inhibitors for all?In: European Heart Journal, Vol. 41, 2020, Nr. 24, pp. 2331
-
Proteome-wide Prediction of Lysine Methylation Leads to Identification of H2BK43 Methylation and Outlines the Potential Methyllysine ProteomeIn: Cell Reports, Vol. 32, 2020, Nr. 2, pp. 107896DOI (Open Access)
-
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors failsIn: Blood, Vol. 135, 2020, Nr. 16, pp. 1386 – 1395DOI (Open Access)
-
Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo : A Secondary Analysis of a Randomized Clinical TrialIn: JAMA Oncology, Vol. 6, 2020, Nr. 4, pp. 519 – 527DOI (Open Access)
-
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV⁶⁰⁰-mutant, stage III melanoma (COMBI-AD) : Exploratory biomarker analyses from a randomised, phase 3 trialIn: The Lancet Oncology, Vol. 21, 2020, Nr. 3, pp. 358 – 372DOI, Online Full Text (Open Access)
-
Strong suppression of gene conversion with increasing DNA double-strand break load delimited by 53BP1 and RAD52In: Nucleic Acids Research, Vol. 48, 2020, Nr. 4, pp. 1905 – 1924DOI (Open Access)
-
Cemiplimab in locally advanced cutaneous squamous cell carcinoma : results from an open-label, phase 2, single-arm trialIn: The Lancet Oncology, Vol. 21, 2020, Nr. 2, pp. 294 – 305DOI, Online Full Text (Open Access)
-
Corrigendum to “Biomolecule-corona formation confers resistance of bacteria to nanoparticle-induced killing: Implications for the design of improved nanoantibiotics”In: Biomaterials. Amsterdam; Oxford: Elsevier, Vol. 263, 2020, pp. 120371
-
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSigIn: Nature Communications, Vol. 11, 2020, 731DOI (Open Access)
-
Pathway and network analysis of more than 2500 whole cancer genomesIn: Nature Communications, Vol. 11, 2020, 729DOI (Open Access)
-
Genomic footprints of activated telomere maintenance mechanisms in cancerIn: Nature Communications, Vol. 11, 2020, 733DOI (Open Access)
-
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterationsIn: Nature Communications, Vol. 11, 2020, 736DOI (Open Access)
-
Inferring structural variant cancer cell fractionIn: Nature Communications, Vol. 11, 2020, 730DOI (Open Access)
-
Integrative pathway enrichment analysis of multivariate omics dataIn: Nature Communications, Vol. 11, 2020, 735DOI (Open Access)
-
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsIn: Nature Communications, Vol. 11, 2020, 728DOI (Open Access)
-
Divergent mutational processes distinguish hypoxic and normoxic tumoursIn: Nature Communications, Vol. 11, 2020, 737DOI (Open Access)
-
Combined burden and functional impact tests for cancer driver discovery using DriverPowerIn: Nature Communications, Vol. 11, 2020, 734DOI (Open Access)
-
Cardiac fibroblast activation detected by positron emission tomography/computed tomography as a possible sign of cardiotoxicityIn: European Heart Journal, Vol. 41, 2020, Nr. 9, pp. 1060
-
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 1335DOI (Open Access)
-
A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus controlIn: Journal of Hepatology, Vol. 72, 2020, Nr. 5, pp. 960 – 975DOI (Open Access)
-
Involvement of Hus1 in the chain elongation step of DNA replication after exposure to camptothecin or ionizing radiationIn: Nucleic Acids Research, Vol. 48, 2020, Nr. 6, pp. 3396DOI (Open Access)
-
Immunotherapeutic blockade of CD47 inhibitory signaling enhances innate and adaptive immune responses to viral infectionIn: Cell Reports, Vol. 31, 2020, Nr. 2, pp. 107494DOI (Open Access)
-
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : A randomised, double-blind, placebo-controlled, phase 2 trialIn: Lancet, Vol. 395, 2020, Nr. 10236, pp. 1558 – 1568
-
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell CarcinomaIn: Clinical Cancer Research, Vol. 26, 2020, Nr. 9, pp. 2257 – 2267DOI (Open Access)
-
Dual pH-Induced Reversible Self-Assembly of Gold Nanoparticles by Surface Functionalization with Zwitterionic LigandsIn: Small, Vol. 16, 2020, Nr. 28, 2001044DOI (Open Access)
-
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv⁶⁰⁰ mutation–positive melanoma receiving adjuvant vemurafenibIn: Annals of Oncology, Vol. 31, 2020, Nr. 1, pp. 153 – 159DOI (Open Access)
-
Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activityIn: Cancer Research, Vol. 80, 2020, Nr. 4, pp. 798 – 810DOI, Online Full Text (Open Access)
-
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityIn: Nature Communications, Vol. 11, 2020, Nr. 1, 4684DOI (Open Access)
-
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s diseaseIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 4885DOI (Open Access)
-
Nusinersen in adults with 5q spinal muscular atrophy : A non-interventional, multicentre, observational cohort studyIn: The Lancet Neurology, Vol. 19, 2020, Nr. 4, pp. 317 – 325
-
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR) : A multicentre, open-label, phase 1 trialIn: The Lancet Oncology, Vol. 21, 2020, Nr. 7, pp. 935 – 946
-
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke : A multicentre, double-blind, randomised, placebo-controlled trialIn: The Lancet Neurology, Vol. 19, 2020, Nr. 3, pp. 226 – 233DOI, Online Full Text (Open Access)
-
Rationale for Immune Checkpoint Inhibitors plus Targeted Therapy in Metastatic Melanoma : A ReviewIn: JAMA Oncology, Vol. 6, 2020, Nr. 12, pp. 1957 – 1966
-
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaIn: Nature Medicine, Vol. 26, 2020, Nr. 7, pp. 1147DOI (Open Access)
-
Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanomaIn: Nature, Vol. 580, 2020, Nr. 7801, pp. E1DOI (Open Access)
-
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaIn: The New England Journal of Medicine, Vol. 383, 2020, Nr. 12, pp. 1139 – 1148DOI, Online Full Text (Open Access)
-
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma : safety run-in and biomarker cohorts of COMBI-iIn: Nature Medicine, Vol. 26, 2020, Nr. 10, pp. 1557 – 1563
-
Anemia increases long-term mortality in patients undergoing conventional coronary angiography – the ECAT registry
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal, Vol. 41, 2020, Nr. Supplement_2, pp. 1508 -
Present and Future of Surface-Enhanced Raman ScatteringIn: ACS Nano, Vol. 14, 2020, Nr. 1, pp. 28 – 117DOI (Open Access)
-
Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injuryIn: Gut, Vol. 69, 2020, Nr. 1, pp. 133 – 145DOI (Open Access)
-
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosisIn: Gut, Vol. 69, 2020, Nr. 7, pp. 1269 – 1282
-
Functional Disruption of the Cancer-Relevant Interaction between Survivin and Histone H3 with a Guanidiniocarbonyl Pyrrole LigandIn: Angewandte Chemie International Edition, Vol. 59, 2020, Nr. 14, pp. 5567 – 5571DOI (Open Access)
-
Heterobifunctional Rotaxanes for Asymmetric CatalysisIn: Angewandte Chemie International Edition, Vol. 59, 2020, Nr. 13, pp. 5102 – 5107DOI (Open Access)
-
Metabolic heterogeneity confers differences in melanoma metastatic potentialIn: Nature, Vol. 577, 2020, Nr. 7788, pp. 115 – 120DOI, Online Full Text (Open Access)
-
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanomaIn: Annals of Oncology, Vol. 31, 2020, Nr. 1, pp. 144 – 152DOI (Open Access)
-
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsIn: Acta Neuropathologica, Vol. 139, 2020, Nr. 2, pp. 243 – 257DOI, Online Full Text (Open Access)
-
Crizotinib in ROS1 and MET deregulated NSCLC-letterIn: Clinical Cancer Research, Vol. 26, 2020, Nr. 7, pp. 1774DOI (Open Access)
-
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer : Clinical and biomarker results from a phase I trialIn: Annals of Oncology, Vol. 31, 2020, Nr. 6, pp. 789 – 797DOI (Open Access)
-
Durable and controlled depletion of neutrophils in miceIn: Nature Communications, Vol. 11, 2020, pp. 2762DOI (Open Access)
-
Auto-inhibition of Mif2/CENP-C ensures centromere-dependent kinetochore assembly in budding yeastIn: The EMBO Journal, Vol. 39, 2020, Nr. 14, pp. e102938DOI, Online Full Text (Open Access)
-
Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signalingIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 3547DOI (Open Access)
-
Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein–protein interactionsIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 3954DOI (Open Access)
-
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapyIn: The Journal of Clinical Investigation (JCI), Vol. 130, 2020, Nr. 8, pp. 4266 – 4281DOI, Online Full Text (Open Access)
-
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide TherapyIn: Gastroenterology, Vol. 158, 2020, Nr. 8, pp. 2180 – 2194DOI (Open Access)
-
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibilityIn: Nature Genetics, Vol. 52, 2020, Nr. 5, pp. 494 – 504DOI, Online Full Text (Open Access)
-
Structural rearrangement of amyloid-β upon inhibitor binding suppresses formation of Alzheimer’s disease related oligomersIn: eLife, Vol. 9, 2020, pp. 59306DOI (Open Access)
-
Co-option of Neutrophil Fates by Tissue EnvironmentsIn: Cell, Vol. 183, 2020, Nr. 5, pp. 1282 – 1297.e18DOI, Online Full Text (Open Access)
-
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 MortalityIn: Cell, Vol. 183, 2020, Nr. 6, pp. 1508 – 1519.e12DOI (Open Access)
-
The quest for efficient trial designs in precision oncologyIn: The Lancet Oncology, Vol. 21, 2020, Nr. 12, pp. 1539 – 1541
-
Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK PathwayIn: Cancer Research, Vol. 80, 2020, Nr. 21, pp. 4655 – 4667DOI (Open Access)
-
Sex differences in oncogenic mutational processesIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 4330DOI (Open Access)
-
Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healingIn: Gut, Vol. 69, 2020, pp. 252 – 263
-
Pan-cancer analysis of whole genomesIn: Nature, Vol. 578, 2020, Nr. 7793, pp. 82 – 93DOI (Open Access)
-
A Supramolecular Stabilizer of the 14-3-3ζ/ERα Protein-Protein Interaction with a Synergistic Mode of ActionIn: Angewandte Chemie International Edition, Vol. 132, 2020, Nr. 13, pp. 5322 – 5325DOI (Open Access)
-
Thyroid Hormone TransportersIn: Endocrine Reviews, Vol. 41, 2020, Nr. 2, pp. 146 – 201DOI (Open Access)
-
A combined experimental and modelling approach for the Weimberg pathway optimisationIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 1098DOI (Open Access)
-
Towards Reliable and Quantitative Surface-Enhanced Raman Scattering (SERS) : From Key Parameters to Good Analytical PracticeIn: Angewandte Chemie International Edition, Vol. 59, 2020, pp. 5454 – 5462DOI (Open Access)
-
Tertiary lymphoid structures improve immunotherapy and survival in melanomaIn: Nature, Vol. 577, 2020, Nr. 7791, pp. 561 – 565
-
Cancer cells stock up in lymph vessels to surviveIn: Nature, Vol. 585, 2020, Nr. 7823, pp. 36 – 37DOI, Online Full Text (Open Access)
-
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced Melanoma : Pooled Analysis of 3 Clinical TrialsIn: JAMA Oncology, Vol. 6, 2020, Nr. 8, pp. 1256 – 1264
-
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis : A retrospective analysis of the HIT ependymoma trial cohortIn: Acta Neuropathologica, Vol. 140, 2020, Nr. 3, pp. 405 – 407DOI (Open Access)
-
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypesIn: Blood, Vol. 136, 2020, Nr. 12, pp. 1419 – 1432DOI, Online Full Text (Open Access)
-
Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to ImmunotherapyIn: Clinical Cancer Research, Vol. 26, 2020, Nr. 21, pp. 5638 – 5645DOI (Open Access)
-
Integrated molecular drivers coordinate biological and clinical states in melanomaIn: Nature Genetics, Vol. 52, 2020, Nr. 12, pp. 1373 – 1383DOI, Online Full Text (Open Access)
-
Peptide and peptide-based inhibitors of SARS-CoV-2 entryIn: Advanced Drug Delivery Reviews, Vol. 167, 2020, pp. 47 – 65DOI (Open Access)
-
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 4748DOI (Open Access)
-
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 6232DOI (Open Access)
-
Optogenetic Tuning Reveals Rho Amplification-Dependent Dynamics of a Cell Contraction Signal NetworkIn: Cell Reports, Vol. 33, 2020, Nr. 9, pp. 108467DOI (Open Access)
-
Survival Outcomes Associated with 3 Years vs 1 Year of Adjuvant Imatinib for Patients with High-Risk Gastrointestinal Stromal Tumors : An Analysis of a Randomized Clinical Trial after 10-Year Follow-upIn: JAMA Oncology, Vol. 6, 2020, Nr. 8, pp. 1241 – 1246
-
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotranspositionIn: Nature Genetics, Vol. 52, 2020, Nr. 3, pp. 306 – 319DOI (Open Access)
-
Glycan-dependent cell adhesion mechanism of Tc toxinsIn: Nature Communications, Vol. 11, 2020, Nr. 1, 2694DOI (Open Access)
-
TranSPHIRE : automated and feedback-optimized on-the-fly processing for cryo-EMIn: Nature Communications, Vol. 11, 2020, Nr. 1, 5716DOI (Open Access)
-
Structural basis for effector transmembrane domain recognition by type vi secretion system chaperonesIn: eLife, Vol. 9, 2020, e62816DOI (Open Access)
-
Structural basis of trpc4 regulation by calmodulin and pharmacological agentsIn: eLife, Vol. 9, 2020, pp. 1 – 58DOI (Open Access)
-
Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myelomaIn: Leukemia, Vol. 33, 2019, Nr. 7, pp. 258 – 261
-
Weightlifting unmasks high-risk coronary anomalyIn: European Heart Journal, Vol. 40, 2019, Nr. 1, pp. 72
-
Microglial cell loss after ischemic stroke favors brain neutrophil accumulationIn: Acta Neuropathologica, Vol. 137, 2019, Nr. 2, pp. 321 – 341DOI (Open Access)
-
Survival Outcomes in Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma Treated with Nivolumab Therapy : Three-Year Follow-up of a Randomized Phase 3 TrialIn: JAMA Oncology, Vol. 5, 2019, Nr. 2, pp. 187 – 194
-
Alpelisib Plus Fulvestrant in PIK3CA -Altered and PIK3CA -Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer : A Phase 1b Clinical TrialIn: JAMA Oncology, Vol. 5, 2019, Nr. 2, pp. e184475DOI (Open Access)
-
The intramembrane protease SPPL2c promotes male germ cell development by cleaving phospholambanIn: EMBO Reports, Vol. 20, 2019, Nr. 3, pp. e46449DOI, Online Full Text (Open Access)
-
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL) : a multicentre, open-label, randomised, controlled phase II trialIn: Annals of Oncology, Vol. 30, 2019, Nr. 2, pp. 317 – 324DOI (Open Access)
-
Biomolecule-corona formation confers resistance of bacteria to nanoparticle-induced killing : Implications for the design of improved nanoantibioticsIn: Biomaterials, Vol. 192, 2019, pp. 551 – 559
-
Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal CancerIn: Immunity, Vol. 50, 2019, Nr. 1, pp. 166 – 180.e7DOI (Open Access)
-
Sites of high local frustration in DNA origamiIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 1061DOI (Open Access)
-
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms Across Eight Psychiatric DisordersIn: Cell, Vol. 179, 2019, Nr. 7, pp. 1469 – 1482.e11.DOI (Open Access)
-
Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD) : a randomised, placebo-controlled, phase 3 trialIn: The Lancet Oncology, Vol. 20, 2019, Nr. 5, pp. 701 – 710
-
Electroporated recombinant proteins as tools for in vivo functional complementation, imaging and chemical biologyIn: eLife, Vol. 8, 2019, pp. e48287DOI (Open Access)
-
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosaIn: Nature Genetics, Vol. 51, 2019, Nr. 8, pp. 1207 – 1214DOI, Online Full Text (Open Access)
-
Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunityIn: FEMS Microbiology Reviews, Vol. 43, 2019, Nr. 5, pp. 435 – 456DOI, Online Full Text (Open Access)
-
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in MelanomaIn: Cell Reports, Vol. 27, 2019, Nr. 12, pp. 3573 – 3586.e7DOI (Open Access)
-
MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearanceIn: Journal of Hepatology, Vol. 71, 2019, Nr. 4, pp. 685 – 698
-
Current gaps in sepsis immunology: new opportunities for translational researchIn: The Lancet Infectious Diseases, Vol. 19, 2019, Nr. 12, pp. e422 – e436DOI (Open Access)
-
Molecular features of the UNC-45 chaperone critical for binding and folding muscle myosinIn: Nature Communications, Vol. 10, 2019, Nr. 1, 4781DOI (Open Access)
-
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression : a phase 1 dose-escalation and dose-expansion studyIn: The Lancet Oncology, Vol. 20, 2019, Nr. 10, pp. 1454 – 1466
-
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4) : A randomised, phase 2/3 trialIn: Lancet, Vol. 393, 2019, Nr. 10184, pp. 1948 – 1957
-
Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3In: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 4919DOI, Online Full Text (Open Access)
-
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal CancerIn: Cancer Research, Vol. 79, 2019, Nr. 9, pp. 2367 – 2378
-
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome PredictionIn: Cell, Vol. 178, 2019, Nr. 3, pp. 699 – 713.e19DOI (Open Access)
-
Treatment in metastatic melanoma : Time to re-thinkIn: Annals of Oncology, Vol. 30, 2019, Nr. 4, pp. 501 – 503DOI (Open Access)
-
Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 2312DOI (Open Access)
-
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphomaIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 1459DOI (Open Access)
-
Control of TLR7-mediated type i IFN signaling in pDCs through CXCR4 engagement - A new target for lupus treatmentIn: Science Advances, Vol. 5, 2019, Nr. 7, pp. eaav9019DOI (Open Access)
-
The ubiquitin-conjugating enzyme UBE2QL1 coordinates lysophagy in response to endolysosomal damageIn: EMBO Reports, 2019, pp. e48014DOI (Open Access)
-
Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell deathIn: Nature, Vol. 569, 2019, Nr. 7755, pp. 236 – 240DOI, Online Full Text (Open Access)
-
Publisher Correction : Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 299DOI (Open Access)
-
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationIn: Nature Medicine, Vol. 25, 2019, Nr. 4, pp. 603 – 611DOI (Open Access)
-
HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapyIn: Cancer Research, Vol. 79, 2019, Nr. 11, pp. 2947 – 2961DOI, Online Full Text (Open Access)
-
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus : the MONO studyIn: Annals of Oncology, Vol. 30, 2019, Nr. 9, pp. 1487 – 1495DOI (Open Access)
-
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaIn: The New England Journal of Medicine, Vol. 381, 2019, Nr. 16, pp. 1535 – 1546DOI (Open Access)
-
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-SelectivityIn: Angewandte Chemie International Edition, Vol. 58, 2019, Nr. 52, pp. 18823 – 18829DOI (Open Access)
-
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and MetastasisIn: Cancer Cell, Vol. 36, 2019, Nr. 3, pp. 319 – 336.e7DOI (Open Access)
-
Melanoma extracellular vesicles generate immunosuppressive myeloid cells by upregulating PD-L1 via TLR4 signalingIn: Cancer Research, Vol. 79, 2019, Nr. 18, pp. 4715 – 4728DOI (Open Access)
-
Axon-like protrusions promote small cell lung cancer migration and metastasisIn: eLife, Vol. 8, 2019, pp. e50616DOI (Open Access)
-
Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphomaIn: Blood, Vol. 134, 2019, Nr. 13, pp. 1072 – 1083DOI (Open Access)
-
Genomes of Subaerial Zygnematophyceae Provide Insights into Land Plant EvolutionIn: Cell, Vol. 179, 2019, Nr. 5, pp. 1057 – 1067.e14DOI (Open Access)
-
Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 299DOI (Open Access)
-
Publisher Correction: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 2768DOI (Open Access)
-
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt LymphomaIn: Cancer Research, Vol. 79, 2019, Nr. 12, pp. 3125 – 3138DOI (Open Access)
-
Mechanism of centromere recruitment of the CENP-A chaperone HJURP and its implications for centromere licensingIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 4046DOI (Open Access)
-
Molecular determinants of the Ska-Ndc80 interaction and their influence on microtubule tracking and force-couplingIn: eLife, Vol. 8, 2019, pp. e49539DOI (Open Access)
-
Five-year outcomes with dabrafenib plus trametinib in metastatic melanomaIn: The New England Journal of Medicine, Vol. 381, 2019, Nr. 7, pp. 626 – 636DOI (Open Access)
-
A TetR-family transcription factor regulates fatty acid metabolism in the archaeal model organism Sulfolobus acidocaldariusIn: Nature Communications, Vol. 10, 2019, Nr. 1, pp. 1542DOI (Open Access)
-
Glycosidase and glycan polymorphism control hydrolytic release of immunogenic flagellin peptidesIn: Science, Vol. 364, 2019, Nr. 6436, eaav0748DOI, Online Full Text (Open Access)
-
Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope ProteinsIn: Cell Reports, Vol. 27, 2019, Nr. 7, pp. 2092 – 2104.e10DOI (Open Access)
-
Understanding HDV and HBsAg kinetics during nucleic acid polymer REP 2139 mono-therapy in HBeAg-negative chronic HBV/HDV co-infected patients via mathematical modelingIn: Journal of Hepatology, Vol. 70, 2019, Nr. 1 Suppl., pp. e463
-
Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infectionIn: Journal of Hepatology, Vol. 70, 2019, Nr. 1 Suppl., pp. e81
-
Viral escape contributes to the failure of hepatitis D virus-specific CD8+ T-cells and drives evolution of HDVIn: Journal of Hepatology, Vol. 70, 2019, Nr. Suppl. 1, pp. e21
-
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8⁺ T Cells and Evolve at the Population LevelIn: Gastroenterology, Vol. 156, 2019, Nr. 6, pp. 1820 – 1833DOI (Open Access)
-
Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancerIn: Annals of Oncology, Vol. 30, 2019, Nr. 4, pp. 655 – 657DOI (Open Access)
-
A newly discovered stem cell that keeps bones growingIn: Nature, Vol. 567, 2019, Nr. 7747, pp. 178 – 179
-
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaIn: Nature Medicine, Vol. 25, 2019, Nr. 12, pp. 1916 – 1927DOI (Open Access)
-
Rapid, Quantitative, and Ultrasensitive Point-of-Care Testing : A Portable SERS Reader for Lateral Flow Assays in Clinical ChemistryIn: Angewandte Chemie International Edition, Vol. 58, 2019, Nr. 2, pp. 442 – 446DOI (Open Access)
-
Cryo-EM structure of the ClpXP protein degradation machineryIn: Nature Structural & Molecular Biology, Vol. 26, 2019, Nr. 10, pp. 946 – 954
-
Profilin and formin constitute a pacemaker system for robust actin filament growthIn: eLife, Vol. 8, 2019, e50963DOI (Open Access)
-
Towards the application of Tc toxins as a universal protein translocation systemIn: Nature Communications, Vol. 10, 2019, Nr. 1, 5263DOI (Open Access)
-
Reconstitution of recombinant human CCR4-NOT reveals molecular insights into regulated deadenylationIn: Nature Communications, Vol. 10, 2019, Nr. 1, 3173DOI (Open Access)
-
Common architecture of Tc toxins from human and insect pathogenic bacteriaIn: Science Advances, Vol. 5, 2019, Nr. 10, eaax6497DOI (Open Access)
-
Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events : Result of the HNR Study (Heinz Nixdorf Recall)In: Circulation, Vol. 137, 2018, Nr. 7, pp. 665 – 679DOI (Open Access)
-
Proteolytic processing of palmitoylated Hedgehog peptides specifies the 3-4 intervein region of the Drosophila wingIn: eLife, Vol. 7, 2018, pp. e33033DOI (Open Access)
-
Insights into the evolutionary conserved regulation of Rio ATPase activity.In: Nucleic Acids Research, Vol. 46, 2018, Nr. 3, pp. 1441 – 1456DOI (Open Access)
-
Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-PrimingIn: Cell Reports, Vol. 22, 2018, Nr. 6, pp. 1484 – 1495DOI (Open Access)
-
Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067)In: Annals of Oncology, Vol. 29, 2018, Nr. Suppl. 8, pp. viii735DOI (Open Access)
-
Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib + trametinib (D + T) in patients (pts) with resected BRAF V600-mutant stage III melanomaIn: Annals of Oncology, Vol. 29, 2018, Nr. Suppl. 8, pp. viii734 – viii735DOI (Open Access)
-
Discovering novel hydrolases from hot environmentsIn: Biotechnology Advances, Vol. 36, 2018, Nr. 8, pp. 2077 – 2100DOI (Open Access)
-
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067) : 4-year outcomes of a multicentre, randomised, phase 3 trialIn: The Lancet Oncology, Vol. 19, 2018, Nr. 11, pp. 1480 – 1492
-
Antidepressants regulate autophagy by targeting acid sphingomyelinaseIn: Molecular Psychiatry, Vol. 23, 2018, Nr. 12, pp. 2251
-
T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexesIn: Nature Biotechnology, Vol. 36, 2018, Nr. 12, pp. 1191 – 1196DOI, Online Full Text (Open Access)
-
A Non-Competitive Inhibitor of VCP/p97 and VPS4 Reveals Conserved Allosteric Circuits in Type I and II AAA ATPasesIn: Angewandte Chemie International Edition, Vol. 57, 2018, Nr. 6, pp. 1576 – 1580
-
Adjuvant pembrolizumab versus placebo in resected stage III melanomaIn: The New England Journal of Medicine, Vol. 378, 2018, Nr. 19, pp. 1789 – 1801DOI, Online Full Text (Open Access)
-
The landscape of genomic alterations across childhood cancersIn: Nature, Vol. 555, 2018, Nr. 7696, pp. 321 – 327DOI (Open Access)
-
DNA methylation-based classification of central nervous system tumoursIn: Nature, Vol. 555, 2018, Nr. 7697, pp. 469 – 474DOI (Open Access)
-
Bortezomib before and after high-dose therapy in myeloma : Long-term results from the phase III HOVON-65/GMMG-HD4 trialIn: Leukemia, Vol. 32, 2018, Nr. 2, pp. 383 – 390DOI (Open Access)
-
Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosaIn: Molecular Psychiatry, Vol. 23, 2018, Nr. 5, pp. 1169 – 1180DOI (Open Access)
-
Hierarchical Assembly of DNA Filaments with Designer Elastic PropertiesIn: ACS Nano, Vol. 12, 2018, Nr. 1, pp. 44 – 55
-
Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individualsIn: Blood, Vol. 131, 2018, Nr. 5, pp. 546 – 557DOI (Open Access)
-
Dynamic kinetochore size regulation promotes microtubule capture and chromosome biorientation in mitosisIn: Nature Cell Biology, Vol. 20, 2018, pp. 800 – 810DOI, Online Full Text (Open Access)
-
An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphomaIn: Leukemia, Vol. 32, 2018, Nr. 1, pp. 92 – 101
-
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable diseaseIn: The Lancet Oncology, Vol. 19, 2018, Nr. 3, pp. e151 – e160DOI, Online Full Text (Open Access)
-
A critical view on transgenerational epigenetic inheritance in humansIn: Nature Communications, Vol. 9, 2018, Nr. 1, pp. 2973DOI (Open Access)
-
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsIn: Nature Genetics, Vol. 50, 2018, Nr. 9, pp. 1271 – 1281DOI, Online Full Text (Open Access)
-
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemiaIn: Nature Communications, Vol. 9, 2018, 3839DOI (Open Access)
-
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell SubsetsIn: Clinical Cancer Research, Vol. 24, 2018, Nr. 19, pp. 4834 – 4844DOI (Open Access)
-
Reconstitution of a 26-Subunit Human Kinetochore Reveals Cooperative Microtubule Binding by CENP-OPQUR and NDC80.In: Molecular Cell, Vol. 71, 2018, Nr. 6, pp. 923 – 939.e10DOI (Open Access)
-
Imaging of coronary inflammation for cardiovascular risk predictionIn: Lancet, Vol. 392, 2018, Nr. 10151, pp. 894 – 896DOI (Open Access)
-
BRCT domains of the DNA damage checkpoint proteins TOPBP1/Rad4 display distinct specificities for phosphopeptide ligandsIn: eLife, Vol. 7, 2018, e39979DOI (Open Access)
-
Correction: Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosaIn: Molecular Psychiatry, Vol. 23, 2018, Nr. 9, pp. 1DOI (Open Access)
-
IG-MYC⁺ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasIn: Blood, Vol. 132, 2018, Nr. 21, pp. 2280 – 2285DOI (Open Access)
-
A mechanistic classification of clinical phenotypes in neuroblastomaIn: Science, Vol. 362, 2018, Nr. 6419, pp. 1165 – 1170DOI, Online Full Text (Open Access)
-
A distinct oncogenerative multinucleated cancer cell serves as a source of stemness and tumor heterogeneityIn: Cancer Research, Vol. 78, 2018, Nr. 9, pp. 2318 – 2331DOI (Open Access)
-
Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinomaIn: Clinical Cancer Research, Vol. 24, 2018, Nr. 23, pp. 5873 – 5882DOI, Online Full Text (Open Access)
-
Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-Cell populationsIn: Clinical Cancer Research, Vol. 24, 2018, Nr. 21, pp. 5347 – 5356DOI, Online Full Text (Open Access)
-
Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA methylation profilingIn: Clinical Cancer Research, Vol. 24, 2018, Nr. 18, pp. 4494 – 4504DOI (Open Access)
-
Notch-induced myeloid reprogramming in spontaneous pancreatic ductal adenocarcinoma by dual genetic targetingIn: Cancer Research, Vol. 78, 2018, Nr. 17, pp. 4997 – 5010DOI (Open Access)
-
PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinomaIn: The New England Journal of Medicine, Vol. 379, 2018, Nr. 4, pp. 341 – 351DOI, Online Full Text (Open Access)
-
Adjuvant melanoma therapy with new drugs : Should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?In: The Lancet Oncology, Vol. 19, 2018, Nr. 12, pp. e720 – e725
-
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2) : An open-label, multicentre, phase 2 trialIn: The Lancet Oncology, Vol. 19, 2018, Nr. 12, pp. 1668 – 1679
-
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS) : A multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology, Vol. 19, 2018, Nr. 10, pp. 1315 – 1327
-
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications, Vol. 9, 2018, Nr. 1, pp. 4774DOI (Open Access)
-
Sphingolipids as targets for inhalation treatment of cystic fibrosisIn: Advanced Drug Delivery Reviews, Vol. 133, 2018, pp. 66 – 75
-
Ideal Dimers of Gold Nanospheres for Precision Plasmonics : Synthesis and Characterization at the Single-Particle Level for Identification of Higher Order ModesIn: Small, Vol. 14, 2018, Nr. 4, 1702754
-
Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone lossIn: Nature Medicine, Vol. 24, 2018, Nr. 5, pp. 667 – 678
-
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO) : a randomised, observer-masked, multicentre trialIn: The Lancet Diabetes and Endocrinology, Vol. 6, 2018, Nr. 4, pp. 287 – 298
-
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS) : a multicentre, open-label, randomised phase 3 trialIn: The Lancet Oncology, Vol. 19, 2018, Nr. 5, pp. 603 – 615DOI (Open Access)
-
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy : a retrospective, multicohort analysisIn: The Lancet Oncology, Vol. 19, 2018, Nr. 3, pp. 310 – 322DOI, Online Full Text (Open Access)
-
CEACAM1 promotes CD8⁺ T cell responses and improves control of a chronic viral infectionIn: Nature Communications, Vol. 9, 2018, 2561DOI (Open Access)
-
Helicobacter pylori adhesin HopQ disrupts trans dimerization in human CEACAMsIn: The EMBO Journal, Vol. 37, 2018, Nr. 13DOI, Online Full Text (Open Access)
-
Human CD30⁺ B cells represent a unique subset related to Hodgkin lymphoma cellsIn: The Journal of Clinical Investigation (JCI), Vol. 128, 2018, Nr. 7, pp. 2996 – 3007DOI, Online Full Text (Open Access)
-
Quantitative Determination of Contribution by Enhanced Local Electric Field, Antenna-Amplified Light Scattering, and Surface Energy Transfer to the Performance of Plasmonic Organic Solar CellsIn: Small, Vol. 14, 2018, Nr. 30, 1800870
-
Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramideIn: Molecular Psychiatry, Vol. 23, 2018, Nr. 12, pp. 2324 – 2346DOI (Open Access)
-
Evolution of the Optical Gap in the Acene Series : UndecaceneIn: Angewandte Chemie International Edition, Vol. 57, 2018, Nr. 33, pp. 10506 – 10509
-
Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumoniaIn: The Journal of Clinical Investigation (JCI), Vol. 128, 2018, Nr. 8, pp. 3535 – 3545DOI (Open Access)
-
Nanomaterial-microbe cross-talk : physicochemical principles and (patho)biological consequencesIn: Chemical Society Reviews, Vol. 47, 2018, Nr. 14, pp. 5312 – 5337
-
Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotypeIn: Hepatology, Vol. 67, 2018, Nr. 4, pp. 1237 – 1252DOI (Open Access)
-
Critical influences on the pathogenesis of follicular lymphomaIn: Blood, Vol. 131, 2018, Nr. 21, pp. 2297 – 2306DOI (Open Access)
-
Cell entry of a host-targeting protein of oomycetes requires gp96In: Nature Communications, Vol. 9, 2018, Nr. 1, pp. 2347DOI (Open Access)
-
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 BlockadeIn: Cell, Vol. 173, 2018, Nr. 3, pp. 624 – 633.e8DOI, Online Full Text (Open Access)
-
Small Meets Smaller : Effects of Nanomaterials on Microbial Biology, Pathology, and EcologyIn: ACS Nano, Vol. 12, 2018, Nr. 7, pp. 6351 – 6359
-
Role of elevated PHIP copy number as a prognostic and progression marker for cutaneous melanomaIn: Clinical Cancer Research, Vol. 24, 2018, Nr. 17, pp. 4119 – 4125DOI, Online Full Text (Open Access)
-
Trade-off shapes diversity in eco-evolutionary dynamicsIn: eLife, Vol. 7, 2018, pp. e36273DOI (Open Access)
-
VCP/p97-Mediated Unfolding as a Principle in Protein Homeostasis and SignalingIn: Molecular Cell, Vol. 69, 2018, Nr. 2, pp. 182 – 194DOI (Open Access)
-
UFD-2 is an adaptor-assisted E3 ligase targeting unfolded proteinsIn: Nature Communications, Vol. 9, 2018, Nr. 1, 484DOI (Open Access)
-
Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trialIn: Annals of Oncology, Vol. 29, 2018, Nr. Suppl. 8, pp. viii446DOI (Open Access)
-
Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trialIn: Annals of Oncology, Vol. 29, 2018, Nr. Suppl. 8, pp. viii445DOI (Open Access)
-
Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib plus trametinib (D plus T) in patients (pts) with resected BRAF V600-mutant stage III melanomaIn: Annals of Oncology, Vol. 29, 2018, Nr. Suppl. 8
-
Author Correction : The landscape of genomic alterations across childhood cancersIn: Nature. London: Springer Nature, Vol. 559, 2018, Nr. 7714, pp. E10
-
Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in miceIn: Hepatology, Vol. 68, 2018, Nr. 1, pp. 200 – 214
-
Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCCIn: Hepatology, Vol. 68, 2018, Nr. Suppl. 1, pp. 852A – 853A
-
Corrigendum: Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cellsIn: EMBO Reports, Vol. 19, 2018, Nr. 12, pp. e47190DOI, Online Full Text (Open Access)
-
Adjuvant vemurafenib in resected, BRAF mutation-positive melanoma (BRIM8) : a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialIn: The Lancet Oncology, Vol. 19, 2018, Nr. 4, pp. 510 – 520
-
Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccinationIn: Nature Communications, Vol. 9, 2018, Nr. 1, pp. 1212DOI (Open Access)
-
Effect of UV irradiation on Sulfolobus acidocaldarius and involvement of the general transcription factor TFB3 in the early UV responseIn: Nucleic Acids Research, Vol. 46, 2018, Nr. 14, pp. 7179 – 7192DOI, Online Full Text (Open Access)
-
B Cell-Mediated Maintenance of Cluster of Differentiation 169–Positive Cells Is Critical for Liver RegenerationIn: Hepatology, Vol. 68, 2018, Nr. 6, pp. 2348 – 2361DOI (Open Access)
-
From Supramolecular Vesicles to Micelles : Controllable Construction of Tumor-Targeting Nanocarriers Based on Host–Guest Interaction between a Pillar[5]arene-Based Prodrug and a RGD-Sulfonate GuestIn: Small, Vol. 14, 2018, Nr. 52, pp. 1803952
-
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeIn: Cell, Vol. 175, 2018, Nr. 4, pp. 984 – 997.e24DOI (Open Access)
-
Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme FormationIn: Molecular Cell, Vol. 72, 2018, Nr. 4, pp. 766 – 777DOI (Open Access)
-
Tc toxin activation requires unfolding and refolding of a β-propellerIn: Nature, Vol. 563, 2018, Nr. 7730, pp. 209 – 233
-
Membrane insertion of α-xenorhabdolysin in near-atomic detailIn: eLife, Vol. 7, 2018, e38017DOI (Open Access)
-
Structural transitions of F-actin upon ATP hydrolysis at near-atomic resolution revealed by cryo-EM /631/535/1258/1259 /631/45/612/1228 /101 /101/28 articleIn: Nature Structural & Molecular Biology, Vol. 25, 2018, Nr. 6, pp. 528 – 537
-
Electron cryo-microscopy structure of the canonical TRPC4 ion channelIn: eLife, Vol. 7, 2018, e36615DOI (Open Access)
-
Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis.In: Nature Communications, Vol. 8, 2017, pp. 1597DOI (Open Access)
-
The greatest kinetochore show on earthIn: EMBO Reports, Vol. 18, 2017, Nr. 9, pp. 1473 – 1475DOI, Online Full Text (Open Access)
-
Molecular basis for inner kinetochore configuration through RWD domain–peptide interactionsIn: The EMBO Journal, Vol. 36, 2017, Nr. 23, pp. 3458 – 3482DOI (Open Access)
-
Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cellsIn: EMBO Reports, Vol. 18, 2017, Nr. 12, pp. 2144 – 2159
-
An NMR Method To Pinpoint Supramolecular Ligand Binding to Basic Residues on ProteinsIn: Angewandte Chemie International Edition, Vol. 56, 2017, Nr. 46, pp. 14758 – 14762
-
Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of klothoIn: Clinical Cancer Research, Vol. 23, 2017, Nr. 12, pp. 3181 – 3190DOI (Open Access)
-
Targeting adenosine in BRAF-mutant melanoma reduces tumor growth and metastasisIn: Cancer Research, Vol. 77, 2017, Nr. 17, pp. 4684 – 4696
-
Visualizing the function and fate of neutrophils in sterile injury and repairIn: Science, Vol. 358, 2017, Nr. 6359, pp. 111 – 116
-
A Binary Bivalent Supramolecular Assembly Platform Based on Cucurbit[8]uril and Dimeric Adapter Protein 14-3-3In: Angewandte Chemie International Edition, Vol. 56, 2017, Nr. 31, pp. 8998 – 9002DOI (Open Access)
-
TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gutIn: Nature Communications, Vol. 8, 2017, Nr. 1, pp. 1917DOI (Open Access)
-
Advanced SERS sensor based on capillarity-assisted preconcentration through gold nanoparticle-decorated porous nanorodsIn: Small, Vol. 13, 2017, Nr. 22, 1603947DOI, Online Full Text (Open Access)
-
Hepatocyte nuclear factor 1A deficiency causes hemolytic anemia in mice by altering erythrocyte sphingolipid homeostasisIn: Blood, Vol. 130, 2017, Nr. 25, pp. 2786 – 2798
-
T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genesIn: Gut, Vol. 66, 2017, Nr. 3, pp. 454 – 463DOI (Open Access)
-
Epigenetic treatment of pancreatic cancer : Is there a therapeutic perspective on the horizon?In: Gut, Vol. 66, 2017, Nr. 1, pp. 168 – 179DOI (Open Access)
-
Lymphocytes Negatively Regulate NK Cell Activity via Qa-1b following Viral InfectionIn: Cell Reports, Vol. 21, 2017, Nr. 9, pp. 2528 – 2540DOI (Open Access)
-
BubR1 Promotes Bub3-Dependent APC/C Inhibition during Spindle Assembly Checkpoint SignalingIn: Current Biology, Vol. 27, 2017, Nr. 19, pp. 2915 – 2927.e7DOI (Open Access)
-
Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivoIn: Cancer Cell, Vol. 31, 2017, Nr. 4, pp. 516 – 531.e10DOI (Open Access)
-
MAPK signaling and inflammation link melanoma phenotype switching to induction of CD73 during immunotherapyIn: Cancer Research, Vol. 77, 2017, Nr. 17, pp. 4697 – 4709
-
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck CancerIn: Cancer Research, Vol. 77, 2017, Nr. 22, pp. 6353 – 6364DOI, Online Full Text (Open Access)
-
Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE) : a randomised, regimen-controlled, double-blind, phase 2 trialIn: The Lancet Oncology, Vol. 18, 2017, Nr. 3, pp. 404 – 412
-
Vemurafenib in metastatic melanoma patients with brain metastases : An open-label, single-arm, phase 2, multicentre studyIn: Annals of Oncology, Vol. 28, 2017, Nr. 3, pp. 634 – 641
-
Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass indexIn: Molecular Psychiatry, Vol. 22, 2017, pp. 192 – 201DOI, Online Full Text (Open Access)
-
Targeting of the Fun30 nucleosome remodeller by the Dpb11 scaffold facilitates cell cycle-regulated DNA end resectionIn: eLife, 2017, Nr. 6, e21687DOI, Online Full Text (Open Access)
-
VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagyIn: The EMBO Journal, Vol. 36, 2017, Nr. 2, pp. 135 – 150DOI (Open Access)
-
Tailored protein encapsulation into a DNA host using geometrically organized supramolecular interactionsIn: Nature Communications, Vol. 8, 2017, pp. 14472DOI, Online Full Text (Open Access)
-
First-line afatinib for advanced EGFRm1 NSCLC : Analysis of long-term responders (LTRs) in the LUX-Lung (LL) 3, 6 and 7 trialsIn: Annals of Oncology, Vol. 28, 2017, Nr. Suppl. 2
-
CDK-regulated dimerization of M18BP1 on a Mis18 hexamer is necessary for CENP-A loadingIn: eLife, Vol. 6, 2017, pp. e23352DOI, Online Full Text (Open Access)
-
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma : long-term survival and safety analysis of a phase 3 studyIn: Annals of Oncology, Vol. 28, 2017, Nr. 7, pp. 1631 – 1639DOI (Open Access)
-
Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AMLIn: Leukemia, Vol. 31, 2017, Nr. 10, pp. 2247 – 2251
-
Myelodysplastic syndromes and bone loss in mice and menIn: Leukemia, Vol. 31, 2017, Nr. 4, pp. 1003 – 1007
-
A phase Ib dose-escalation study of encorafenib and cetuximab with or without alpelisib in metastatic BRAF-mutant colorectal cancerIn: Cancer Discovery, Vol. 7, 2017, Nr. 6, pp. 610 – 619DOI, Online Full Text (Open Access)
-
Co-clinical assessment of tumor cellularity in pancreatic cancerIn: Clinical Cancer Research, Vol. 23, 2017, Nr. 6, pp. 1461 – 1470
-
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patientsIn: Cancer Research, Vol. 77, 2017, Nr. 4, pp. P1 – 01
-
Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer : Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)In: Annals of Oncology, Vol. 28, 2017, Nr. Suppl. 5
-
A novel mRNA-based patient selection strategy identifies fibroblast growth factor receptor (FGFR) inhibitor-sensitive tumors : Results from rogaratinib Phase-1 studyIn: Annals of Oncology, Vol. 28, 2017, Nr. Suppl. 5
-
Subsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm plus ) NSCLC in LUX-Lung (LL) 3, 6 and 7In: Annals of Oncology, Vol. 28, 2017, Nr. Suppl. 5
-
Lost in neutrophil heterogeneity? : CD10!In: Blood, Vol. 129, 2017, Nr. 10, pp. 1240 – 1241DOI (Open Access)
-
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCTIn: Blood, Vol. 130, 2017, Nr. 10, pp. 1270 – 1273
-
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trialIn: Annals of Oncology, Vol. 28, 2017, Nr. 5, pp. 1084 – 1089DOI (Open Access)
-
EV-TRACK : Transparent reporting and centralizing knowledge in extracellular vesicle researchIn: Nature Methods, Vol. 14, 2017, Nr. 3, pp. 228 – 232
-
Detection and Clearance of Damaged Lysosomes by the Endo-Lysosomal Damage Response and LysophagyIn: Current Biology, Vol. 27, 2017, Nr. 24, pp. R1330 – R1341
-
HLA-DP in unrelated hematopoietic cell transplantation revisited : Challenges and opportunitiesIn: Blood, Vol. 130, 2017, Nr. 9, pp. 1089 – 1096DOI (Open Access)
-
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of MelanomaIn: Cell Reports, Vol. 21, 2017, Nr. 7, pp. 1953 – 1967DOI (Open Access)
-
Morphology-Dependent Cell Imaging by Using a Self-Assembled Diacetylene Peptide AmphiphileIn: Angewandte Chemie International Edition, Vol. 56, 2017, Nr. 46, pp. 14526 – 14530
-
Efficient Gene Transfection through Inhibition of β-Sheet (Amyloid Fiber) Formation of a Short Amphiphilic Peptide by Gold NanoparticlesIn: Angewandte Chemie International Edition, Vol. 56, 2017, Nr. 28, pp. 8083 – 8088
-
Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine modelsIn: Hepatology, Vol. 66, 2017, Nr. 1, pp. 69 – 83
-
Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression : Analysis of 2 Phase 3 Clinical TrialsIn: JAMA Oncology, Vol. 3, 2017, Nr. 11, pp. 1511 – 1519DOI, Online Full Text (Open Access)
-
Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasisIn: Acta Neuropathologica, Vol. 133, 2017, Nr. 3, pp. 463 – 483DOI (Open Access)
-
Decoding the centromeric nucleosome through CENP-NIn: eLife, Vol. 6, 2017, pp. e33442DOI (Open Access)
-
Tailored Ahp-cyclodepsipeptides as Potent Non-covalent Serine Protease InhibitorsIn: Angewandte Chemie International Edition, Vol. 56, 2017, Nr. 29, Special Issue: 100th Anniversary of the Royal Australian Chemical Institute, pp. 8555 – 8558
-
Functional Mechanically Interlocked Molecules : Asymmetric Organocatalysis with a Catenated Bifunctional Brønsted AcidIn: Angewandte Chemie International Edition, Vol. 56, 2017, Nr. 38, pp. 11456 – 11459
-
Integrative analysis identifies four molecular and clinical subsets in uveal melanomaIn: Cancer Cell, Vol. 32, 2017, Nr. 2, pp. 204 – 220.e15DOI (Open Access)
-
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPIn: The Lancet Oncology, Vol. 18, 2017, Nr. 4, pp. 454 – 463
-
Plasmonic hot electron transport drives nano-localized chemistryIn: Nature Communications, Vol. 8, 2017, 14880DOI (Open Access)
-
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growthIn: Nature Communications, Vol. 8, 2017, pp. 14600DOI (Open Access)
-
Spatiotemporally restricted arenavirus replication induces immune surveillance and type i interferon-dependent tumour regressionIn: Nature Communications, Vol. 8, 2017, pp. 14447DOI (Open Access)
-
Site-Specific SERS Assay for Survivin Protein Dimer : From Ensemble Experiments to Correlative Single-Particle ImagingIn: Small, Vol. 13, 2017, Nr. 32, pp. 1700802
-
Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4-and MYC-dependent mannerIn: Nucleic Acids Research, Vol. 45, 2017, Nr. 11, pp. 6334 – 6349DOI (Open Access)
-
Predictors of responses to immune checkpoint blockade in advanced melanomaIn: Nature Communications, Vol. 8, 2017, pp. 592DOI (Open Access)
-
Irf4-dependent CD103+CD11b+ dendritic cells and the intestinal microbiome regulate monocyte and macrophage activation and intestinal peristalsis in postoperative ileusIn: Gut, Vol. 66, 2017, Nr. 12, pp. 2110 – 2120DOI, Online Full Text (Open Access)
-
Acquired IFNγ 3 resistance impairs anti-Tumor immunity and gives rise to T-cell-resistant melanoma lesionsIn: Nature Communications, Vol. 8, 2017, 15440DOI (Open Access)
-
Activity-based protein profiling as a robust method for enzyme identification and screening in extremophilic ArchaeaIn: Nature Communications, Vol. 8, 2017, pp. 15352DOI (Open Access)
-
Laser Synthesis and Processing of Colloids : Fundamentals and ApplicationsIn: Chemical Reviews, Vol. 117, 2017, Nr. 5, pp. 3990 – 4103
-
Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial functionIn: Nature Communications, Vol. 8, 2017, pp. 480DOI (Open Access)
-
BLIMP1 induces transient metastatic heterogeneity in pancreatic cancerIn: Cancer Discovery, Vol. 7, 2017, Nr. 10, pp. 1184 – 1199
-
Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axisIn: Nature Medicine, Vol. 23, 2017, Nr. 3, pp. 291 – 300DOI, Online Full Text (Open Access)
-
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma : a randomised, double-blind, multicentre, phase 3 trialIn: The Lancet Oncology, Vol. 18, 2017, Nr. 5, pp. 611 – 622
-
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO) : a multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology, Vol. 18, 2017, Nr. 4, pp. 435 – 445
-
Prognostic mutations in myelodysplastic syndrome after stem-cell transplantationIn: The New England Journal of Medicine, Vol. 376, 2017, Nr. 6, pp. 536 – 547DOI (Open Access)
-
Basis of catalytic assembly of the mitotic checkpoint complexIn: Nature, Vol. 542, 2017, Nr. 7642, pp. 498 – 502DOI, Online Full Text (Open Access)
-
Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic PlasticityIn: Gastroenterology, Vol. 152, 2017, Nr. 6, pp. 1507 – 1520.e15DOI (Open Access)
-
Three-Dimensional Cross-Sectional Light-Sheet Microscopy Imaging of the Inflamed Mouse GutIn: Gastroenterology, Vol. 153, 2017, Nr. 4, pp. 898 – 900
-
Hepatitis B virus production is enhanced through early autophagic flux but degraded through autophagosome-lysosome fusionIn: Journal of Hepatology, Vol. 66, 2017, Nr. 1, pp. S701
-
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma : a prospective multicentre trial by the German Cooperative PCNSL study groupIn: Leukemia, Vol. 31, 2017, Nr. 12, pp. 2623 – 2629
-
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)In: Leukemia, Vol. 31, 2017, Nr. 4, pp. 846 – 852DOI (Open Access)
-
Inactivation of Capicua drives cancer metastasisIn: Nature Genetics, Vol. 49, 2017, Nr. 1, pp. 87 – 96DOI, Online Full Text (Open Access)
-
Overall survival with combined nivolumab and ipilimumab in advanced melanomaIn: The New England Journal of Medicine, Vol. 377, 2017, Nr. 14, pp. 1345 – 1356DOI, Online Full Text (Open Access)
-
Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanomaIn: The New England Journal of Medicine, Vol. 377, 2017, Nr. 19, pp. 1813 – 1823DOI, Online Full Text (Open Access)
-
Efficacy and safety of nilotinib in patients with kit-mutated metastatic or inoperable melanoma : Final results from the global, single-arm, phase ii team trialIn: Annals of Oncology, Vol. 28, 2017, Nr. 6, pp. 1380 – 1387DOI (Open Access)
-
Architecture and mechanism of the late endosomal Rab7-like Ypt7 guanine nucleotide exchange factor complex Mon1-Ccz1In: Nature Communications, Vol. 8, 2017, 14034DOI (Open Access)
-
Structural basis for tRNA-dependent cysteine biosynthesisIn: Nature Communications, Vol. 8, 2017, Nr. 1, 1521DOI (Open Access)
-
A recombinant BBSome core complex and how it interacts with ciliary cargoIn: eLife, Vol. 6, 2017, e27434DOI (Open Access)
-
Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical TrialsIn: Clinical Cancer Research, Vol. 22, 2016, Nr. 3, pp. 567 – 574DOI (Open Access)
-
VCP/p97 Extracts Sterically Trapped Ku70/80 Rings from DNA in Double-Strand Break RepairIn: Molecular Cell, Vol. 64, 2016, Nr. 1, pp. 189 – 198DOI (Open Access)
-
Targeting MYCN-driven transcription by BET-bromodomain inhibitionIn: Clinical Cancer Research, Vol. 22, 2016, Nr. 10, pp. 2470 – 2781DOI (Open Access)
-
Towards quantitative multi-color nanodiagnostics : spectral multiplexing with six silica-encapsulated SERS labelsIn: Angewandte Chemie International Edition, Vol. 47, 2016, Nr. 9, pp. 1012 – 1016
-
CCAN Assembly Configures Composite Binding Interfaces to Promote Cross-Linking of Ndc80 Complexes at the KinetochoreIn: Current Biology, Vol. 26, 2016, Nr. 17, pp. 2370 – 2378DOI, Online Full Text (Open Access)
-
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsIn: Neuro-Oncology, Vol. 18, 2016, Nr. 6, pp. 790 – 796DOI (Open Access)
-
Molecular basis of outer kinetochore assembly on CENP-TIn: eLife, Vol. 5, 2016, pp. e21007DOI (Open Access)
-
Use of an Octapeptide–Guanidiniocarbonylpyrrole Conjugate for the Formation of a Supramolecular β-Helix that Self-Assembles into pH-Responsive FibersIn: Angewandte Chemie International Edition, Vol. 55, 2016, Nr. 42, pp. 13015 – 13018
-
A Force-Induced Directional Switch of a Molecular Motor Enables Parallel Microtubule Bundle FormationIn: Cell, Vol. 167, 2016, Nr. 2, pp. 539 – 552.e14DOI, Online Full Text (Open Access)
-
Structure of the MIS12 Complex and Molecular Basis of Its Interaction with CENP-C at Human KinetochoresIn: Cell, Vol. 167, 2016, Nr. 4, pp. 1028 – 1040.e15DOI (Open Access)
-
Insights from biochemical reconstitution into the architecture of human kinetochoresIn: Nature, Vol. 537, 2016, Nr. 7619, pp. 249 – 253
-
Characterizing the Effect of Multivalent Conjugates Composed of Aβ-Specific Ligands and Metal Nanoparticles on Neurotoxic Fibrillar AggregationIn: ACS Nano, 2016, pp. 7582 – 7597
-
Microtubules : 50 years on from the discovery of tubulinIn: Nature Reviews Molecular Cell Biology, Vol. 17, 2016, Nr. 5, pp. 322 – 328DOI, Online Full Text (Open Access)
-
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemiaIn: Nature Genetics, Vol. 48, 2016, Nr. 3, pp. 253 – 264DOI, Online Full Text (Open Access)
-
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphomaIn: Leukemia, Vol. 30, 2016, Nr. 4, pp. 844 – 853
-
ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinomaIn: Nucleic Acids Research, Vol. 44, 2016, Nr. 7, pp. 3204 – 3218DOI (Open Access)
-
Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinomaIn: The Journal of Clinical Investigation (JCI), Vol. 126, 2016, Nr. 11, pp. 4187 – 4204
-
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaIn: Blood, Vol. 128, 2016, Nr. 23, pp. 2666 – 2670DOI (Open Access)
-
Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung FibrosisIn: Cancer Research, Vol. 76, 2016, Nr. 10, pp. 3045 – 3056DOI (Open Access)
-
Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCTIn: Blood, Vol. 128, 2016, Nr. 1, pp. 120 – 129DOI (Open Access)
-
Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexiaIn: Nature Communications, Vol. 7, 2016, pp. 12528DOI (Open Access)
-
Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietinIn: The Journal of Clinical Investigation (JCI), Vol. 126, 2016, Nr. 4, pp. 1425 – 1437
-
Checkpoint inhibitors : a new standard of care for advanced Merkel cell carcinoma?In: The Lancet Oncology, Vol. 17, 2016, Nr. 10, pp. 1337 – 1339
-
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with IpilimumabIn: Clinical Cancer Research, Vol. 22, 2016, Nr. 19, pp. 4848 – 4858
-
Adjuvant treatment with pegylated interferon ?-2a versus low-dose interferon ?-2a in patients with high-risk melanoma : a randomized phase III DeCOG trialIn: Annals of Oncology, Vol. 27, 2016, Nr. 8, pp. 1625 – 1632DOI (Open Access)
-
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeIn: Science, Vol. 351, 2016, Nr. 6280, pp. 1463 – 1469
-
Breast cancer-derived extracellular vesicles : clinical and prognostic impactIn: Cancer Research, Vol. 76, 2016, Nr. 14 Suppl., pp. 3152
-
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIOIn: The Lancet Oncology, Vol. 17, 2016, Nr. 12, pp. 1697 – 1708
-
Chromosome thripsis by DNA double strand break clusters causes enhanced cell lethality, chromosomal translocations and 53BP1-recruitmentIn: Nucleic Acids Research, Vol. 44, 2016, Nr. 16, pp. 7673 – 7690DOI (Open Access)
-
Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growthIn: Neuro-Oncology, Vol. 18, 2016, Nr. 4, pp. 538 – 548DOI (Open Access)
-
Incorporation of a Non-Natural Arginine Analogue into a Cyclic Peptide Leads to Formation of Positively Charged Nanofibers Capable of Gene TransfectionIn: Angewandte Chemie International Edition, Vol. 55, 2016, Nr. 2, pp. 598 – 601
-
Circulating HIV-Specific Interleukin-21In: Immunity, Vol. 44, 2016, Nr. 1, pp. 167 – 178DOI (Open Access)
-
Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphateIn: Journal of Hepatology, Vol. 64, 2016, Nr. 1, pp. 60 – 68DOI, Online Full Text (Open Access)
-
Next-generation metabolic imaging in pancreatic cancerIn: Gut, Vol. 65, 2016, Nr. 3, pp. 367 – 369
-
Quantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamersIn: Nature Communications, Vol. 7, 2016, pp. 13047DOI (Open Access)
-
PD-L1 expression as a biomarker for nivolumab (NIVO) plus ipilimumab (IPI) and NIVO alone in advanced melanoma (MEL) : A pooled analysisIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. 1112PD
-
Cetuximab biweekly (q2w) plus mFOLFOX6 as 1st line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) – Primary endpoint and subgroup analysis of the CEBIFOX trialIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl.6, pp. 508P
-
Analysis of patient-reported outcomes by disease progression status in patients (pts) with BRAF V600–mutant metastatic melanoma in the COMBI-d and COMBI-v trialsIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. 1140P
-
Three-year estimate of overall survival in COMBI-v, a randomized phase 3 study evaluating first-line dabrafenib (D) + trametinib (T) in patients (pts) with unresectable or metastatic BRAF V600E/K–mutant cutaneous melanomaIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. LBA40
-
Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE studyIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. 1152P
-
Health-related quality-of-life (HRQOL) impact of dabrafenib (D) and trametinib (T) vs BRAF inhibitor (BRAFi) monotherapy by lactate dehydrogenase (LDH) in patients (pts) with BRAF V600–mutant melanomaIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. 1137P
-
Pooled analysis of factors to predict durable clinical outcomes with combination dabrafenib (D) and trametinib (T) across registration trialsIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. 1134P
-
GFI1 as a novel prognostic and therapeutic factor for AML/MDSIn: Leukemia, Vol. 30, 2016, Nr. 6, pp. 1237 – 1245
-
The International Human Epigenome Consortium : A Blueprint for Scientific Collaboration and DiscoveryIn: Cell, Vol. 167, 2016, Nr. 5, pp. 1145 – 1149DOI (Open Access)
-
Time to Give Up on Cardioprotection? : A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote ConditioningIn: Circulation Research, Vol. 119, 2016, Nr. 5, pp. 676 – 695
-
Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic LatencyIn: Cancer Research, Vol. 76, 2016, Nr. 15, pp. 4347 – 4358
-
Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 NexusIn: Cell Reports, Vol. 17, 2016, Nr. 6, pp. 1571 – 1583DOI (Open Access)
-
Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment : a pooled analysis of individual patient data from randomised trialsIn: The Lancet Oncology, Vol. 17, 2016, Nr. 12, pp. 1743 – 1754
-
JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral CancersIn: Cancer Research, Vol. 76, 2016, Nr. 18, pp. 5538 – 5549
-
Baseline Biomarkers for Outcome of Melanoma Patients Treated with PembrolizumabIn: Clinical Cancer Research, Vol. 22, 2016, Nr. 22, pp. 5487 – 5496DOI (Open Access)
-
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with IpilimumabIn: Clinical Cancer Research, Vol. 22, 2016, Nr. 12, pp. 2908 – 2918DOI (Open Access)
-
Functional inhibition of mesenchymal stromal cells in acute myeloid leukemiaIn: Leukemia, Vol. 30, 2016, Nr. 3, pp. 683 – 691
-
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger) : a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma NIn: Lancet, Vol. 388, 2016, Nr. 10044, pp. 565 – 575
-
The bulk of the hematopoietic stem cell population is dispensable for murine steady-state and stress hematopoiesisIn: Blood, Vol. 128(19), 2016, pp. 2285 – 2296
-
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia : The AML-AZA trial of the Study Alliance LeukemiaIn: Leukemia, Vol. 30, 2016, Nr. 3, pp. 555 – 561
-
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib : phase III randomized LUX-Lung 5 trialIn: Annals of Oncology, Vol. 27, 2016, Nr. 3, pp. 417 – 423DOI (Open Access)
-
TGF-β receptor maintains CD4 T helper cell identity during chronic viral infectionsIn: The Journal of Clinical Investigation (JCI), Vol. 126, 2016, Nr. 10, pp. 3799 – 3813
-
Antiviral CD8(+) T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal ExpansionIn: Immunity, Vol. 45, 2016, Nr. 4, pp. 917 – 930DOI (Open Access)
-
A Functional Role for Antibodies in TuberculosisIn: Cell, Vol. 167, 2016, Nr. 2, pp. 433 – 443.e14DOI (Open Access)
-
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER studyIn: Journal of Hepatology, Vol. 65, 2016, Nr. 2, pp. 280 – 288
-
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1) : updated results from the multicentre, open-label, phase 1 trialIn: The Lancet Oncology, Vol. 17, 2016, Nr. 4, pp. 452 – 463DOI, Online Full Text (Open Access)
-
IMAB362 : a novel immunotherapeutic antibody targeting the tight-junction protein component CLAUDIN18.2 in gastric cancerIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 2, pp. ii141 – ii142
-
Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC) : phase 2 resultsIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 2, pp. ii127 – ii128
-
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma : post hoc analyses of the randomized LUX-Lung 3 and 6 trialsIn: Annals of Oncology, Vol. 27, 2016, Nr. 11, pp. 2103 – 2110DOI (Open Access)
-
Protein phosphorylation and its role in archaeal signal transductionIn: FEMS Microbiology Reviews, Vol. 40, 2016, Nr. 5, pp. 625 – 647DOI (Open Access)
-
Competitive solvent-molecule interactions govern primary processes of diphenylcarbene in solvent mixturesIn: Nature Communications, Vol. 7, 2016, pp. 12968DOI (Open Access)
-
developmental therapeuticsPhase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levelsIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, 360O_PR
-
Final overall survival for KEYNOTE-002 : pembrolizumab (pembro) versus investigator-choice chemotherapy (chemo) for ipilimumab (ipi)-refractory melanomaIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. 1107O
-
Analysis of BRAF V600E mutation status – concordance of results from circulating tumor DNA and tissue-based testing and impact on prediction of the clinical course in patients undergoing BRAFi therapyIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. 1145P
-
A phase I, open-label study of pasireotide in patients with BRAF- and NRAS-wild type, unresectable and or metastatic melanomaIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6
-
Angelman syndrome-insights into a rare neurogenetic disorderIn: Nature Reviews Neurology, Vol. 12, 2016, Nr. 10, pp. 584 – 593
-
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosisIn: Acta Neuropathologica, Vol. 132, 2016, Nr. 1, pp. 149 – 151
-
Evaluation of real world treatment outcomes in patients with metastatic merkel cell carcinoma (MCC) following second line chemotherapyIn: Annals of Oncology, Vol. 27, 2016, Nr. Suppl. 6, pp. vi397DOI (Open Access)
-
Modular PROTAC Design for the Degradation of Oncogenic BCR-ABLIn: Angewandte Chemie International Edition, Vol. 55, 2016, Nr. 2, pp. 807 – 810
-
1236P - Global named patient use (NPU) program of afatinib, an oral ErbB family blocker, in heavily pretreated advanced non-small cell lung carcinoma (NSCLC) patients who progressed following prior therapies, including erlotinib or gefitinib (E/G)In: Annals of Oncology, Vol. 27, 2016, Nr. Supplement 6, pp. vi427
-
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistanceIn: Nature, Vol. 532, 2016, Nr. 7598, pp. 250 – 254DOI, Online Full Text (Open Access)
-
Molecular requirements for the inter-subunit interaction and kinetochore recruitment of SKAP and AstrinIn: Nature Communications, Vol. 7, 2016, pp. 11407DOI (Open Access)
-
Membrane insertion of a Tc toxin in near-atomic detailIn: Nature Structural & Molecular Biology, Vol. 23, 2016, Nr. 10, pp. 884 – 890DOI (Open Access)
-
Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolutionIn: Nature, Vol. 534, 2016, Nr. 7609, pp. 724 – 728DOI (Open Access)
-
Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphomaIn: Blood, Vol. 126, 2015, Nr. 10, pp. 1257 – 1258
-
A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma : pretreatment impacts survivalIn: Annals of Oncology, Vol. 26, 2015, Nr. 3, pp. 573 – 582DOI (Open Access)
-
Human TLR8 senses UR/URR motifs in bacterial and mitochondrial RNAIn: EMBO Reports, Vol. 16, 2015, Nr. 12, pp. 1656 – 1663DOI (Open Access)
-
Covalent-Allosteric Kinase InhibitorsIn: Angewandte Chemie International Edition, Vol. 54, 2015, Nr. 35, pp. 10313 – 10316
-
Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in miceIn: Nature Biotechnology, Vol. 33, 2015, Nr. 1, pp. 81 – 88
-
Phase I study of the PI3K alpha inhibitor BYL719 plus fulvestrant in patients with PIK3CA-altered and wild type ER+/HER2-locally advanced or metastatic breast cancerIn: Cancer Research, Vol. 75, 2015, Nr. S 9, pp. 9 – 13
-
Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectableIn: Journal of Hepatology, Vol. 63, 2015, Nr. 1, pp. 13 – 19
-
Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutationsIn: The New England Journal of Medicine, Vol. 373, 2015, Nr. 8, pp. 726 – 736DOI, Online Full Text (Open Access)
-
Identification of human telomerase assembly inhibitors enabled by a novel method to produce hTERTIn: Nucleic Acids Research, Vol. 43, 2015, Nr. 15, art. no. e99DOI (Open Access)
-
Determinants of amyloid fibril degradation by the PDZ protease HTRA1In: Nature Chemical Biology, Vol. 11, 2015, Nr. 11, pp. 862 – 869DOI, Online Full Text (Open Access)
-
CEACAM1 induces B-cell survival and is essential for protective antiviral antibody productionIn: Nature Communications, Vol. 6, 2015, 6217DOI (Open Access)
-
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer : Results from the European EURAF CohortIn: Annals of Oncology, Vol. 26, 2015, Nr. S 1: European Lung Cancer Conference (ELCC), Geneva, Switzerland, 15-18 April 2015 : Abstracts, pp. i61
-
Nivolumab in previously untreated melanoma without BRAF mutationIn: The New England Journal of Medicine, Vol. 372, 2015, Nr. 4, pp. 311 – 319DOI, Online Full Text (Open Access)
-
A Tailor-Made Specific Anion-Binding Motif in the Side Chain Transforms a Tetrapeptide into an Efficient Vector for Gene DeliveryIn: Angewandte Chemie International Edition, Vol. 54, 2015, Nr. 10, pp. 2941 – 2944
-
Regulation of hematogenous tumor metastasis by acid sphingomyelinaseIn: EMBO Molecular Medicine, Vol. 7, 2015, Nr. 6, pp. 714 – 734DOI (Open Access)
-
DNA-directed assembly of capture tools for constitutional studies of large protein complexesIn: Small, Vol. 11, 2015, Nr. 22, pp. 2669 – 2674
-
Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesisIn: Hepatology, Vol. 61, 2015, Nr. 6, pp. 2042 – 2055DOI (Open Access)
-
Closing the Mad2 cycle : chromosome separation is regulated by a cycle that involves a protein undergoing an unusual topological conversionIn: eLife, Vol. 4, 2015, pp. e08283DOI (Open Access)
-
A molecular basis for the differential roles of Bub1 and BubR1 in the spindle assembly checkpointIn: eLife, Vol. 4, 2015, pp. e05269DOI (Open Access)
-
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations : A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6In: The Lancet Oncology, Vol. 16, 2015, Nr. 7, pp. 830 – 838
-
Site-Directed, on-surface assembly of DNA nanostructuresIn: Angewandte Chemie International Edition, Vol. 54, 2015, Nr. 41, pp. 12039 – 12043
-
The nanoparticle biomolecule corona : lessons learned – challenge accepted?In: Chemical Society Reviews, Vol. 44, 2015, Nr. 17, pp. 6094 – 6121DOI (Open Access)
-
Hot electron-induced reduction of small molecules on photorecycling metal surfacesIn: Nature Communications, Vol. 6, 2015, 7570DOI (Open Access)
-
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanomaIn: Nature Genetics, Vol. 47, 2015, Nr. 9, pp. 987 – 995DOI, Online Full Text (Open Access)
-
Genomic and epigenomic co-evolution in follicular lymphomasIn: Leukemia, Vol. 29, 2015, Nr. 2, pp. 456 – 463
-
Genomic correlates of response to CTLA-4 blockade in metastatic melanomaIn: Science, Vol. 350, 2015, Nr. 6257, pp. 207 – 211DOI, Online Full Text (Open Access)
-
Disease kinetics for decision-making in advanced melanoma : a call for scenario-driven strategy trialsIn: The Lancet Oncology, Vol. 16, 2015, Nr. 13, pp. e522 – e526
-
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with IpilimumabIn: Clinical Cancer Research, Vol. 21, 2015, Nr. 24, pp. 5453 – 5459DOI (Open Access)
-
Pembrolizumab versus Ipilimumab in Advanced MelanomaIn: The New England Journal of Medicine, Vol. 372, 2015, Nr. 26, pp. 2521 – 2532
-
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaIn: The New England Journal of Medicine, Vol. 373, 2015, Nr. 1, pp. 23 – 34DOI, Online Full Text (Open Access)
-
Expanded access programmes : patient interests versus clinical trial integrityIn: The Lancet Oncology, Vol. 16, 2015, Nr. 1, pp. 15 – 17
-
Improved overall survival in melanoma with combined dabrafenib and trametinibIn: The New England Journal of Medicine, Vol. 372, 2015, Nr. 1, pp. 30 – 39DOI, Online Full Text (Open Access)
-
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v) : results of a phase 3, open-label, randomised trialIn: The Lancet Oncology, Vol. 16, 2015, Nr. 13, pp. 1389 – 1398
-
Catchup : a mouse model for imaging-based tracking and modulation of neutrophil granulocytesIn: Nature Methods, Vol. 12, 2015, Nr. 5, pp. 445 – 452
-
Telomerase activation by genomic rearrangements in high-risk neuroblastomaIn: Nature, Vol. 526, 2015, Nr. 7575, pp. 700 – 704DOI, Online Full Text (Open Access)
-
The Functional Distance Between Mismatched HLA-DPB1 Increases Risks of Relapse and Mortality after Unrelated Donor Hematopoietic Cell Transplantation for AML, ALL and MDS : A Refinement of the T Cell Epitope Group Algorithm for Permissive MismatchesIn: Blood, Vol. 126, 2015, Nr. 23, pp. 4288
-
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems SerologyIn: Cell, Vol. 163, 2015, Nr. 4, pp. 988 – 998DOI (Open Access)
-
AIDS virus seeks refuge in B cell folliclesIn: Nature Medicine, Vol. 21, 2015, Nr. 2, pp. 111 – 112
-
IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infectionIn: Nature Communications, Vol. 6, 2015, pp. 7562DOI (Open Access)
-
Outcomes of Primary and Secondary Transformed B-Cell LymphomasIn: Blood, Vol. 126, 2015, Nr. 23
-
Balance shift between error-free and error prone DNA double-strand break repair as a novel mechanism of radiosensitization by nucleoside analogsIn: Cancer Research, Vol. 75, 2015, Nr. Suppl. 15, pp. 3629
-
Mutational dynamics between primary and relapse neuroblastomasIn: Nature Genetics, Vol. 47, 2015, Nr. 8, pp. 872 – 877
-
Immunogenetics of HLA-DP--A New View of Permissible MismatchesIn: The New England Journal of Medicine, Vol. 373, 2015, Nr. 7, pp. 669 – 672
-
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantationIn: Leukemia, Vol. 29, 2015, Nr. 5, pp. 1143 – 1152
-
Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemiaIn: Leukemia, Vol. 29, 2015, Nr. 4, pp. 981 – 984
-
Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient miceIn: Circulation Research, Vol. 116, 2015, Nr. 8, pp. e57 – e68DOI (Open Access)
-
Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patientsIn: Annals of Oncology, Vol. 26, 2015, Nr. 6, pp. 1238 – 1244DOI (Open Access)
-
HJURP involvement in De Novo CenH3CENP-A and CENP-C recruitmentIn: Cell Reports, Vol. 11, 2015, Nr. 1, pp. 22 – 32DOI (Open Access)
-
CEACAM1-3S drives melanoma cells into NK cell-mediated cytolysis and enhances patient survivalIn: Cancer Research, Vol. 75, 2015, Nr. 9, pp. 1897 – 1907DOI (Open Access)
-
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma : a multicentre, double-blind, phase 3 randomised controlled trialIn: Lancet, Vol. 386, 2015, Nr. 9992, pp. 444 – 451
-
Overall survival (OS) with afatinib (A) vs chemotherapy (CT) in patients (pts) with NSCLC harboring EGFR mutations (mut) : Subgroup analyses by race in LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)In: Annals of Oncology, Vol. 26, 2015, Nr. S 9: ESMO Asia Congress, 18-21 December 2015, Singapore : Submitted Abstracts, pp. 136
-
Afatinib (A) versus chemotherapy (CT) for EGFR mutation-positive NSCLC patients (pts) aged ≥65 years : Subgroup analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)In: Annals of Oncology, Vol. 26, 2015, Nr. S 9: ESMO Asia Congress, 18-21 December 2015, Singapore : Submitted Abstracts, pp. 136 – 137
-
Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC)In: Annals of Oncology, Vol. 26, 2015, Nr. S 6, pp. vi73 – vi89
-
Afatinib (a) plus paclitaxel (p) following progression on a monotherapy in patients (pts) with metastatic non-small-cell lung cancer (nsclc) who previously benefited from erlotinib (e)/gefitinib (g) : a global randomised phase iii triallux-lung 5 (ll5)In: Annals of Oncology, Vol. 26, 2015, Nr. S 1, pp. i33 – i34
-
Adaptation of the Hepatitis B Virus Core Protein to CD8+ T-Cell Selection PressureIn: Hepatology, Vol. 62, 2015, Nr. 1, pp. 47 – 56DOI (Open Access)
-
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activityIn: Blood, Vol. 125, 2015, Nr. 8, pp. 1207 – 1216DOI (Open Access)
-
Reversible reconfiguration of DNA origami nanochambers monitored by single-molecule FRETIn: Angewandte Chemie International Edition, Vol. 54, 2015, Nr. 12, pp. 3592 – 3597
-
The (phospho) needle in the (MELT) haystackIn: Molecular Cell, Vol. 57, 2015, Nr. 5, pp. 765 – 766DOI (Open Access)
-
Non-catalytic motor domains enable processive movement and functional diversification of the kinesin-14 Kar3In: eLife, Vol. 4, 2015, pp. e04489DOI (Open Access)
-
Mutations in NLRP5 are associated with reproductive wastage and multilocus imprinting disorders in humansIn: Nature Communications, Vol. 6, 2015, pp. 8086DOI (Open Access)
-
Functional divergence of two secreted immune proteases of tomatoIn: Current Biology, Vol. 25, 2015, Nr. 17, pp. 2300 – 2306DOI (Open Access)
-
A molecular tweezer antagonizes seminal amyloids and HIV infectionIn: eLife, Vol. 4, 2015, Nr. 8, pp. e05397DOI (Open Access)
-
NEMO : A phase 3 trial of binimetinib (MEK162) versus dacarbazine in patients with advanced NRAS-mutant melanoma who are untreated or have progressed on or after immunotherapyIn: Cancer Research, Vol. 75, 2015, Nr. Suppl. 14, pp. B16
-
Targeting super-enhancer induced gene expression with the novel BRD4 inhibitor OTX015 in preclinical models of MYCN-amplified neuroblastomaIn: Cancer Research, Vol. 75, 2015, Nr. 15 Suppl., pp. 4731
-
Endothelial cells isolated from colorectal carcinoma exhibit tumor microenvironment-dependent plasticity allowing the identification of SPARCL1 as a novel endothelial cell quiescence factorIn: Cancer Research, Vol. 75, 2015, Nr. 15 Suppl., pp. 2375
-
Alternative tumor suppressor mechanisms in lung carcinomas - modulation of senescence by growth factor-induced signalingIn: Cancer Research, Vol. 75, 2015, Nr. 15 Suppl., pp. 1033
-
Telomerase activation by genomic rearrangements in high-risk neuroblastomaIn: Cancer Research, Vol. 75, 2015, Nr. 15 Suppl., pp. LB – 210
-
Final biomarker analysis of the phase I study of the selective BRAF V600 inhibitor encorafenib (LGX818) combined with cetuximab with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF-mutant colorectal cancerIn: Cancer Research, Vol. 75, 2015, Nr. 15 Suppl., pp. CT136
-
Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD) : Results from a Prospective Phase II Trial (DECADE Trial)In: Blood, Vol. 126, 2015, Nr. 23, pp. 274
-
Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive LymphomasIn: Blood, Vol. 126, 2015, Nr. 23
-
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): Final results of the multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology, Vol. 16, 2015, Nr. 8, pp. 979 – 989
-
Genomic Classification of Cutaneous MelanomaIn: Cell, Vol. 161, 2015, Nr. 7, pp. 1681 – 1696DOI (Open Access)
-
Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental strokeIn: Acta Neuropathologica, Vol. 129, 2015, Nr. 2, pp. 259 – 277
-
Whole-genome fingerprint of the DNA methylome during human B cell differentiationIn: Nature Genetics, Vol. 47, 2015, Nr. 7, pp. 746 – 756DOI, Online Full Text (Open Access)
-
Progressive epigenetic programming during B cell maturation yields a continuum of clonal disease phenotypes with distinct etiologies in chronic lymphocytic leukemiaIn: Clinical Cancer Research, Vol. 21, 2015, Nr. 17 Suppl., pp. B25 – B25
-
Recurrent CDKN1B (p27) mutations in hairy cell leukemiaIn: Blood, Vol. 126, 2015, Nr. 8, pp. 1005 – 1008
-
Origins of major archaeal clades correspond to gene acquisitions from bacteriaIn: Nature, Vol. 517, 2015, Nr. 7532, pp. 77 – 80DOI, Online Full Text (Open Access)
-
Telomerase Inhibitor Imetelstat in Patients with Essential ThrombocythemiaIn: The New England Journal of Medicine, Vol. 373, 2015, Nr. 10, pp. 920 – 928DOI (Open Access)
-
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blastsIn: Blood, Vol. 126, 2015, Nr. 3, pp. 291 – 299
-
Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectinIn: Nature Communications, Vol. 6, 2015, pp. 6416DOI (Open Access)
-
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal HemoglobinuriaIn: The New England Journal of Medicine, Vol. 373, 2015, Nr. 11, pp. 1032 – 1039DOI (Open Access)
-
The Molecular Biology of Spindle Assembly Checkpoint Signaling DynamicsIn: Current Biology, Vol. 25, 2015, Nr. 20, pp. R1002 – R1018DOI (Open Access)
-
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002) : a randomised, controlled, phase 2 trialIn: The Lancet Oncology, Vol. 16, 2015, Nr. 8, pp. 908 – 918
-
Conjugated Bilirubin Triggers Anemia by Inducing Erythrocyte DeathIn: Hepatology, Vol. 61, 2015, Nr. 1, pp. 275 – 284DOI (Open Access)
-
DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional controlIn: Nature Genetics, Vol. 47, 2015, Nr. 11, pp. 1316 – 1325DOI, Online Full Text (Open Access)
-
Progressive Epigenetic Programming during B Cell Maturation Is Reflected in a Continuum of Epigenetic Disease Phenotypes in Chronic Lymphocytic LeukemiaIn: Blood, Vol. 126, 2015, Nr. 23, pp. 2436
-
Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritisIn: JAMA Neurology, Vol. 72, 2015, Nr. 11, pp. 1281 – 1287DOI (Open Access)
-
Comprehensive genomic profiles of small cell lung cancerIn: Nature, Vol. 524, 2015, Nr. 7563, pp. 47 – 53DOI (Open Access)
-
The Nuclear Pore-Associated TREX-2 Complex Employs Mediator to Regulate Gene ExpressionIn: Cell, Vol. 162, 2015, Nr. 5, pp. 1016 – 1028DOI (Open Access)
-
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6) : analysis of overall survival data from two randomised, phase 3 trialsIn: The Lancet Oncology, Vol. 16, 2015, Nr. 2, pp. 141 – 151
-
Condensation Agents Determine the Temperature–Pressure Stability of F-Actin BundlesIn: Angewandte Chemie International Edition, Vol. 54, 2015, Nr. 38, pp. 11088 – 11092DOI (Open Access)
-
Architecture and conformational switch mechanism of the ryanodine receptorIn: Nature, Vol. 517, 2015, Nr. 7532, pp. 39 – 43DOI (Open Access)
-
An Interbacterial NAD(P)⁺ Glycohydrolase Toxin Requires Elongation Factor Tu for Delivery to Target CellsIn: Cell, Vol. 163, 2015, Nr. 3, pp. 607 – 619DOI (Open Access)
-
Structure of the F-actin-tropomyosin complexIn: Nature, Vol. 519, 2015, Nr. 7541, pp. 114 – 117DOI (Open Access)
-
Surface-Enhanced Raman Spectroscopy : Concepts and Chemical ApplicationsIn: Angewandte Chemie International Edition, Vol. 53, 2014, Nr. 19, pp. 4756 – 4795
-
Unveiling the Correlation between Nanometer-Thick Molecular Monolayer Sensitivity and Near-Field Enhancement and Localization in Coupled Plasmonic OligomersIn: ACS Nano, Vol. 8, 2014, Nr. 9, pp. 9188 – 9198DOI (Open Access)
-
Alarmins MRP8 and MRP14 Induce Stress Tolerance in Phagocytes under Sterile Inflammatory ConditionsIn: Cell Reports, Vol. 9, 2014, Nr. 6, pp. 2112 – 2123DOI (Open Access)
-
The Origin of the Obesity Associated Pomc DNA Hypermethylation VariantIn: Endocrine Reviews, Vol. 35, 2014, Nr. Suppl. 3
-
HLA-B*27 is protective against HCV genotype 1 and 3 and associated with targeting of distinct genotype-specific CD8(+) cell epitopesIn: Journal of Hepatology, Vol. 60, 2014, Nr. Suppl. 1, pp. 140
-
T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish patients with Merkel cell carcinoma from healthy donorsIn: Clinical Cancer Research, Vol. 20, 2014, Nr. 7, pp. 1768 – 1778
-
A facile method for preparation of tailored scaffolds for DNA-origamiIn: Small, Vol. 10, 2014, Nr. 1, pp. 73 – 77
-
Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorderIn: Molecular Psychiatry, Vol. 19, 2014, Nr. 1, pp. 115 – 121DOI (Open Access)
-
Surrogate endpoints for overall survival in metastatic melanoma: A meta-analysis of randomised controlled trialsIn: The Lancet Oncology, Vol. 15, 2014, Nr. 3, pp. 297 – 304
-
When Mad met BubIn: EMBO Reports, Vol. 15, 2014, Nr. 4, pp. 326 – 328DOI, Online Full Text (Open Access)
-
KI motifs of human Knl1 enhance assembly of comprehensive spindle checkpoint complexes around MELT repeatsIn: Current Biology, Vol. 24, 2014, Nr. 1, pp. 29 – 39DOI (Open Access)
-
Modular Assembly of RWD Domains on the Mis12 Complex Underlies Outer Kinetochore OrganizationIn: Molecular Cell, Vol. 53, 2014, Nr. 4, pp. 591 – 605DOI (Open Access)
-
A microRNA involved in the germinal center reactionIn: Blood, Vol. 124, 2014, Nr. 2, pp. 158 – 159DOI, Online Full Text (Open Access)
-
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021) : A multicentric randomized trialIn: Annals of Oncology, Vol. 25, 2014, Nr. 3, pp. 742 – 746
-
Melanoma in 2013 : Melanoma - The run of success continuesIn: Nature Reviews Clinical Oncology, Vol. 11, 2014, Nr. 2, pp. 75 – 76
-
The PRDX2 gene is transcriptionally silenced and de novo methylated in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphomaIn: Blood, Vol. 123, 2014, Nr. 23, pp. 3672 – 3674
-
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma : Quality-of-life analyses of the METRIC studyIn: Annals of Oncology, Vol. 25, 2014, Nr. 3, pp. 700 – 706
-
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanomaIn: Annals of Oncology, Vol. 25, 2014, Nr. 3, pp. 747 – 753
-
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans : A multicenter phase II DeCOG Trial with Long-Term Follow-UpIn: Clinical Cancer Research, Vol. 20, 2014, Nr. 2, pp. 499 – 510
-
Circulating nitrite contributes to cardioprotection by remote ischemic preconditioningIn: Circulation Research, Vol. 114, 2014, Nr. 10, pp. 1601 – 1610
-
The ceramide system as a novel antidepressant targetIn: Trends in Pharmacological Sciences, Vol. 35, 2014, Nr. 6, pp. 293 – 304
-
KIR2DL3+NKG2A− natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugsIn: Journal of Hepatology, Vol. 61, 2014, Nr. 3, pp. 475 – 481
-
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphomaIn: Blood, Vol. 123, 2014, Nr. 8, pp. 1187 – 1198
-
Leveraging Cross-Species Transcription Factor Binding Site Patterns : From Diabetes Risk Loci to Disease MechanismsIn: Cell, Vol. 156, 2014, Nr. 1-2, pp. 343 – 358DOI (Open Access)
-
Targeting and activation of antigen-specific B-cells by calcium phosphate nanoparticles, loaded with protein antigenIn: Biomaterials, Vol. 35, 2014, Nr. 23, pp. 6098 – 6105
-
Progression of coronary artery calcification seems to be inevitable, but predictable-results of the Heinz Nixdorf Recall (HNR) studyIn: European Heart Journal, Vol. 35, 2014, Nr. 42, pp. 2960 – 2971DOI (Open Access)
-
Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosaIn: EMBO Molecular Medicine, Vol. 6, 2014, Nr. 9, pp. 1205 – 1214DOI (Open Access)
-
The pseudo GTPase CENP-M drives human kinetochore assemblyIn: eLife, Vol. 3, 2014, pp. e02978DOI (Open Access)
-
Supratentorial ependymomas of childhood carry C11orf95–RELA fusions leading to pathological activation of the NF-κB signaling pathwayIn: Acta Neuropathologica, Vol. 127, 2014, Nr. 4, pp. 609 – 611
-
Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancerIn: Cancer Research, Vol. 74, 2014, Nr. 16, pp. 4258 – 4269
-
Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loopIn: Cancer Research, Vol. 74, 2014, Nr. 17, pp. 4772 – 4782
-
Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by Melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanomaIn: Clinical Cancer Research, Vol. 20, 2014, Nr. 16, pp. 4390 – 4399
-
Inhibitor-3 ensures bipolar mitotic spindle attachment by limiting association of SDS22 with kinetochore-bound protein phosphatase-1In: The EMBO Journal, Vol. 33, 2014, Nr. 22, pp. 2704 – 2720DOI, Online Full Text (Open Access)
-
Peripheral immune signatures and survival in stage IV melanomaIn: Cancer Research, Vol. 74, 2014, Nr. 19 Suppl., pp. 2547
-
Regulation of the functional interface between nucleotide excision repair and transcription by MITF modulates melanoma growthIn: Cancer Research, Vol. 74, 2014, Nr. 19 Suppl., pp. 2950
-
A chemical inhibitor of jasmonate signaling targets JAR1 in Arabidopsis thalianaIn: Nature Chemical Biology, Vol. 10, 2014, Nr. 10, pp. 830 – 836
-
Break-induced replication repair of damaged forks induces genomic duplications in human cellsIn: Science, Vol. 343, 2014, Nr. 6166, pp. 88 – 91DOI, Online Full Text (Open Access)
-
Lenalidomide and dexamethasone in transplant-ineligible patients with myelomaIn: The New England Journal of Medicine, Vol. 371, 2014, Nr. 10, pp. 906 – 917
-
Pathogenesis, diagnosis, and treatment of composite lymphomasIn: The Lancet Oncology, Vol. 15, 2014, Nr. 10, pp. e435 – 46
-
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy : report of a large prospective multicenter trialIn: Blood, Vol. 124, 2014, Nr. 26, pp. 3870 – 3879
-
A dominant-negative GFI1B mutation in the gray platelet syndromeIn: The New England Journal of Medicine, Vol. 370, 2014, Nr. 3, pp. 245 – 253DOI (Open Access)
-
Myeloid-derived suppressor cells predict survival of patients with advanced melanoma : Comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cellsIn: Clinical Cancer Research, Vol. 20, 2014, Nr. 6, pp. 1601 – 1609
-
A genome-wide association study of anorexia nervosaIn: Molecular Psychiatry, Vol. 19, 2014, Nr. 10, pp. 1085 – 1094DOI, Online Full Text (Open Access)
-
Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)In: Blood, Vol. 124, 2014, Nr. 21, pp. 391
-
Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicityIn: Immunity, Vol. 40, 2014, Nr. 6, pp. 949 – 960DOI (Open Access)
-
Splenic macrophages induce chemotherapy resistance via DNA damage repairIn: Cancer Research, Vol. 74, 2014, Nr. Suppl. 19, pp. 3771
-
Characterization of the DNA Methylome during Human B-Cell DifferentiationIn: Blood, Vol. 124, 2014, Nr. 21, pp. 4346
-
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanomaIn: Nature, Vol. 507, 2014, Nr. 7490, pp. 109 – 113
-
Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3) : extended follow-up of a phase 3, randomised, open-label studyIn: The Lancet Oncology, Vol. 15, 2014, Nr. 3, pp. 323 – 332DOI, Online Full Text (Open Access)
-
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanomaIn: The New England Journal of Medicine, Vol. 371, 2014, Nr. 20, pp. 1877 – 1888DOI (Open Access)
-
The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic MelanomaIn: Cancer Discovery, Vol. 4, 2014, Nr. 1, pp. 94 – 109
-
Genome-wirde DNA copy number analysis of choroid plexus tumorsIn: Neuro-Oncology, Vol. 16, 2014, Nr. Suppl. 1, pp. 134
-
Toll-like receptor 3-acivated non-parenchymal liver cells control hepadnaviral replication in HBV-transgenic mice lacking the surface antigen (HBsAg)In: Hepatology, Vol. 60, 2014, Nr. Suppl. 1, pp. 1022ADOI (Open Access)
-
Ceritinib in ALK-Rearranged Non–Small-Cell Lung CancerIn: The New England Journal of Medicine, Vol. 370, 2014, Nr. 13, pp. 1189 – 1197DOI, Online Full Text (Open Access)
-
Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumorsIn: Cancer Research, Vol. 74, 2014, Nr. 19 Suppl.
-
Ceritinib (LDK378) for treatment of patients with ALK-rearranged (ALK plus) non small cell lung cancer (NSCLO) and brain metastases (BM) in the ascend-1 trialIn: Neuro-Oncology, Vol. 16, 2014, Nr. Suppl. 5, pp. v39
-
Supratentorial ependymomas of childhood carry C11orf95-rela fusions leading to activation of the NF-KB signalling pathwayIn: Neuro-Oncology, Vol. 16, 2014, Nr. Suppl. 1, pp. i24
-
Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-?B signaling pathwayIn: Acta Neuropathologica, Vol. 127, 2014, Nr. 4, pp. 609 – 611
-
Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joiningIn: Nucleic Acids Research, Vol. 42, 2014, Nr. 10, pp. 6380 – 6392DOI (Open Access)
-
Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclastsIn: Nature Communications, Vol. 5, 2014, pp. 5215DOI (Open Access)
-
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialIn: Neuro-Oncology, Vol. 16, 2014, Nr. 12, pp. 1630 – 1638DOI, Online Full Text (Open Access)
-
Genetic evolution of T-cell resistance in the course of melanoma progressionIn: Clinical Cancer Research, Vol. 20, 2014, Nr. 24, pp. 6593 – 6604
-
Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutationIn: The New England Journal of Medicine, Vol. 371, 2014, Nr. 9, pp. 880 – 882
-
MSC-derived exosomes : a novel tool to treat therapy-refractory graft-versus-host diseaseIn: Leukemia, Vol. 28, 2014, Nr. 4, pp. 970 – 973
-
Successful Treatment of a Patient with Extreme Insulin Resistance Due to High Levels of Insulin Receptor Autoantibodies (Type B Insulin Resistance) with RituximabIn: Endocrine Reviews, Vol. 35, 2014, Nr. 3 Suppl.
-
LIN28B drives neuroblastoma oncogenesis through let7-MYCN signalingIn: Cancer Research, Vol. 73, 2013, Nr. 8 Suppl. 1, pp. 4596
-
Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific P13K inhibitor in combination with fulvestrant : Results from a phase I studyIn: Cancer Research, Vol. 73, 2013, Nr. Suppl. 24
-
Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivoIn: Cancer Cell, Vol. 23, 2013, Nr. 1, pp. 77 – 92DOI (Open Access)
-
A Randomized Trial Of Daily Prednisone Versus Pulsed Dexamethasone In Treatment Naïve Patients With Idiopathic Thrombocytopenic PurpuraIn: Blood, Vol. 122, 2013, Nr. 21, pp. 325
-
Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemiaIn: Cancer Cell, Vol. 23, 2013, Nr. 2, pp. 200 – 214DOI (Open Access)
-
Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trialIn: Leukemia, Vol. 27, 2013, Nr. 10, pp. 2102 – 2105
-
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architectureIn: Nature Genetics, Vol. 45, 2013, Nr. 5, pp. 501 – 512
-
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemiaIn: Leukemia, Vol. 27, 2013, Nr. 8, pp. 1782 – 1785
-
Identification of a Heteromeric Complex That Promotes DNA Replication Origin Firing in Human CellsIn: Science, Vol. 340, 2013, Nr. 6135, pp. 981 – 984
-
Streamlining chemical probe discovery : libraries of "fully functionalized" small molecules for phenotypic screeningIn: Angewandte Chemie International Edition, Vol. 52, 2013, Nr. 5, pp. 1368 – 1370
-
Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopesIn: Journal of Hepatology, Vol. 58, 2013, Nr. 1, pp. 24 – 30
-
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma : A phase 2 double-blind randomised studyIn: The Lancet Oncology, Vol. 14, 2013, Nr. 8, pp. 733 – 740
-
Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic LineagesIn: Cell Reports, Vol. 3, 2013, Nr. 5, pp. 1539 – 1552
-
ERCC1 isoform expression and DNA repair in non-small-cell lung cancerIn: The New England Journal of Medicine, Vol. 368, 2013, Nr. 12, pp. 1101 – 1110
-
Role of early B-cell factor 1 (EBF1) in Hodgkin lymphomaIn: Leukemia, Vol. 27, 2013, Nr. 3, pp. 671 – 679
-
HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesisIn: Blood, Vol. 121, 2013, Nr. 8, pp. 1436 – 1445
-
Silver as Antibacterial Agent : Ion, Nanoparticle, and MetalIn: Angewandte Chemie International Edition, Vol. 52, 2013, Nr. 6, pp. 1636 – 1653
-
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiologyIn: Nature Nanotechnology, Vol. 8, 2013, Nr. 10, pp. 772 – 781
-
SIAH proteins : Critical roles in leukemogenesisIn: Leukemia, Vol. 27, 2013, Nr. 4, pp. 792 – 802
-
Bub3 reads phosphorylated MELT repeats to promote spindle assembly checkpoint signalingIn: eLife, Vol. 2, 2013, pp. e01030DOI (Open Access)
-
Utilizing Combinatorial Chemistry and Rational Design : Peptidic Tweezers with Nanomolar Affinity to DNA Can Be Transformed into Efficient Vectors for Gene Delivery by Addition of a Lipophilic TailIn: Angewandte Chemie International Edition, Vol. 52, 2013, Nr. 52, pp. 14016 – 14020
-
XCtpB assembles a gated protease tunnel regulating cell-cell signaling during spore formation in bacillus subtilisIn: Cell, Vol. 155, 2013, Nr. 3, pp. 647 – 658
-
DNA double-strand-break complexity levels and their possible contributions to the probability for error-prone processing and repair pathway choiceIn: Nucleic Acids Research, Vol. 41, 2013, Nr. 16, pp. 7589 – 7605DOI (Open Access)
-
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3In: Nature Genetics, Vol. 45, 2013, Nr. 8, pp. 933 – 936
-
MicroRNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradationIn: Acta Neuropathologica, Vol. 126, 2013, Nr. 2, pp. 251 – 265
-
Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammationIn: Blood, Vol. 121, 2013, Nr. 24, pp. 4930 – 4937
-
Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infectionIn: The Lancet Infectious Diseases, Vol. 13, 2013, Nr. 9, pp. 745 – 751
-
Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral responseIn: Cell Reports, Vol. 4, 2013, Nr. 4, pp. 689 – 696DOI (Open Access)
-
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomasIn: Clinical Cancer Research, Vol. 19, 2013, Nr. 12, pp. 3143 – 3152
-
Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugsIn: Nature Medicine, Vol. 19, 2013, Nr. 7, pp. 934 – 938
-
DOG1 Regulates Growth and IGFBP5 in Gastrointestinal Stromal TumorsIn: Cancer Research, Vol. 73, 2013, Nr. 12, pp. 3661 – 3670
-
Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease controlIn: Clinical Cancer Research, Vol. 19, 2013, Nr. 8, pp. 2232 – 2239
-
A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF InhibitionIn: Cancer Discovery, Vol. 3, 2013, Nr. 3, pp. 351 – 362
-
Characterisation of retinoblastomas without RB1 mutations: Genomic, gene expression, and clinical studiesIn: The Lancet Oncology, Vol. 14, 2013, Nr. 4, pp. 327 – 334
-
A role for LFA-1 in delaying T-lymphocyte egress from lymph nodesIn: The EMBO Journal, Vol. 32, 2013, Nr. 6, pp. 829 – 843
-
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: A non-randomised, open-label phase 2 studyIn: The Lancet Oncology, Vol. 14, 2013, Nr. 3, pp. 249 – 256
-
TERT promoter mutations in familial and sporadic melanomaIn: Science, Vol. 339, 2013, Nr. 6122, pp. 959 – 961
-
“How I Chose Research on Proteases or, More Correctly, How it Chose Me”In: Angewandte Chemie International Edition, Vol. 52, 2013, Nr. 1, pp. 68 – 73
-
BLT-humanized C57BL/6 Rag2⁻/⁻γc⁻/⁻CD47⁻/⁻ mice are resistant to GVHD and develop B- and T-cell immunity to HIV infectionIn: Blood, Vol. 122, 2013, Nr. 25, pp. 4013 – 4020DOI, Online Full Text (Open Access)
-
Conjunctival Melanomas Harbor BRAF and NRAS Mutations—ResponseIn: Clinical Cancer Research, Vol. 19, 2013, Nr. 22, pp. 6331 – 6332
-
Targeting CD4+ T-helper cells improves the induction of antitumor responses in dendritic cell -based vaccinationIn: Cancer Research, Vol. 73, 2013, Nr. 1, pp. 19 – 29
-
Framingham risk score and cardiovascular risk profiles in HIV+ patients and HIV- controls differ by sexIn: European Heart Journal, Vol. 34, 2013, Nr. Suppl. 1, pp. P5164
-
It takes a CAD to kill a tumor cell with a LMPIn: Cancer Cell, Vol. 24, 2013, Nr. 3, pp. 279 – 281DOI (Open Access)
-
Immunomodulation in response to radiation-induced lung injuryIn: Cancer Research, Vol. 73, 2013, Nr. Suppl. 8, pp. 79
-
The Myosin Chaperone UNC-45 Is Organized in Tandem Modules to Support Myofilament Formation in C. elegansIn: Cell, Vol. 152, 2013, Nr. 1-2, pp. 183 – 195DOI (Open Access)
-
Cellular immune reactions in the lungIn: Immunological Reviews, Vol. 251, 2013, Nr. 1, pp. 189 – 214
-
Vemurafenib reverses immunosuppression by myeloid derived suppressor cellsIn: Cancer Research, Vol. 73, 2013, Nr. 8 Suppl., pp. 4714
-
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and humanIn: Nature, Vol. 483, 2012, Nr. 7389, pp. 350 – 354
-
Common variants at 6q22 and 17q21 are associated with intracranial volumeIn: Nature Genetics, Vol. 44, 2012, Nr. 5, pp. 539 – 544
-
The human GFI136N variant induces epigenetic changes at the Hoxa9 locus and accelerates K-RAS driven myeloproliferative disorder in miceIn: Blood, Vol. 120, 2012, Nr. 19, pp. 4006 – 4017
-
Preclinical Testing of a Novel Axl-Kinase Inhibitor in Chronic Lymphocytic LeukemiaIn: Blood, Vol. 120, 2012, Nr. 21
-
Protein Kinase C-beta Dependent Activation of NF-kappa B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in VivoIn: Blood, Vol. 120, 2012, Nr. 21, pp. 314
-
Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)In: Blood, Vol. 120, 2012, Nr. 21, pp. 3512
-
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin : a randomized phase II trial in elderly patientsIn: Annals of Oncology, Vol. 23, 2012, Nr. 4, pp. 990 – 996
-
AML Bone Marrow Microenvironment Impairs Dendritic Cell Maturation and Antigen PresentationIn: Blood, Vol. 120, 2012, Nr. 21, -
-
Early autologous stem cell transplantation for chronic lymphocytic leukemia : long-term follow-up of the German CLL Study Group CLL3 trialIn: Blood, Vol. 119, 2012, Nr. 21, pp. 4851 – 4859
-
Genome-wide H4 K16 acetylation by SAS-I is deposited independently of transcription and histone exchangeIn: Nucleic Acids Research, Vol. 40, 2012, Nr. 1, pp. 65 – 74DOI (Open Access)
-
Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin systemIn: Nature Cell Biology, Vol. 14, 2012, Nr. 2, pp. 117 – 123
-
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17pIn: Blood, Vol. 119, 2012, Nr. 4, pp. 940 – 948
-
Functional redundancy between DNA ligases i and III in DNA replication in vertebrate cellsIn: Nucleic Acids Research, Vol. 40, 2012, Nr. 6, pp. 2599 – 2610DOI (Open Access)
-
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomasIn: Neuro-Oncology, Vol. 14, 2012, Nr. 7, pp. 859 – 869DOI (Open Access)
-
Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formationIn: Nature Cell Biology, Vol. 14, 2012, Nr. 9, pp. 958 – 965
-
A genome-wide association meta-analysis identifies new childhood obesity lociIn: Nature Genetics, Vol. 44, 2012, Nr. 5, pp. 526 – 531
-
Role of the Mad2 dimerization interface in the spindle assembly checkpoint independent of kinetochoresIn: Current Biology, Vol. 22, 2012, Nr. 20, pp. 1900 – 1908
-
The spindle-assembly checkpoint and the beauty of self-destructionIn: Nature Structural & Molecular Biology, Vol. 19, 2012, Nr. 11, pp. 1059 – 1061
-
Newly folded substrates inside the molecular cage of the HtrA chaperone DegQIn: Nature Structural & Molecular Biology, Vol. 19, 2012, Nr. 2, pp. 152 – 157
-
Targeting Taspase1 for Cancer Therapy—LetterIn: Cancer Research, Vol. 72, 2012, Nr. 11, pp. 2912
-
Identification of a selective, activity-based probe for glyceraldehyde 3-phosphate dehydrogenasesIn: Angewandte Chemie International Edition, Vol. 51, 2012, Nr. 21, pp. 5230 – 5233
-
Common variants at 12q15 and 12q24 are associated with infant head circumferenceIn: Nature Genetics, Vol. 44, 2012, Nr. 5, pp. 532 – 538
-
Improved survival with MEK inhibition in BRAF-mutated melanomaIn: The New England Journal of Medicine, Vol. 367, 2012, Nr. 2, pp. 107 – 114
-
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infectionIn: Leukemia, Vol. 26, 2012, Nr. 7, pp. 1654 – 1662
-
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemiaIn: Leukemia, Vol. 26, 2012, Nr. 7, pp. 1475 – 1481
-
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiationIn: Leukemia, Vol. 26, 2012, Nr. 9, pp. 2039 – 2051
-
Prognostic Impact of Vitamin B6 Metabolism in Lung CancerIn: Cell Reports, Vol. 2, 2012, Nr. 2, pp. 257 – 269DOI (Open Access)
-
Promoting brain remodelling and plasticity for stroke recovery : Therapeutic promise and potential pitfalls of clinical translationIn: The Lancet Neurology, Vol. 11, 2012, Nr. 4, pp. 369 – 380
-
Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosisIn: Blood, Vol. 119, 2012, Nr. 24, pp. 5931 – 5942
-
Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signalingIn: Nucleic Acids Research, Vol. 40, 2012, Nr. 5, pp. 1928 – 1943DOI (Open Access)
-
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cellsIn: EMBO Molecular Medicine, Vol. 4, 2012, Nr. 7, pp. 577 – 593DOI (Open Access)
-
Priming of Natural Killer Cells by Nonmucosal Mononuclear Phagocytes Requires Instructive Signals from Commensal MicrobiotaIn: Immunity, Vol. 37, 2012, Nr. 1, pp. 171 – 186
-
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with epcampositive relapsed or refractory advanced-stage breast cancerIn: Annals of Oncology, Vol. 23, 2012, Nr. 9, pp. 2306 – 2313DOI (Open Access)
-
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphomaIn: Blood, Vol. 120, 2012, Nr. 23, pp. 4609 – 4620
-
Advances and perspectives in immunotherapy of melanomaIn: Annals of Oncology, Vol. 23, 2012, Nr. Suppl. 10, pp. x104 – x108
-
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB) : A multicentre, open-label, phase 2 trialIn: The Lancet Oncology, Vol. 13, 2012, Nr. 11, pp. 1087 – 1095
-
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppressionIn: Nature Genetics, Vol. 44, 2012, Nr. 11, pp. 1199 – 1206
-
TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance - Forming modificationIn: Science, Vol. 337, 2012, Nr. 6098, pp. 1111 – 1115
-
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencingIn: Nature Genetics, Vol. 44, 2012, Nr. 12, pp. 1316 – 1320
-
Pmt1, a Dnmt2 homolog in Schizosaccharomyces pombe, mediates tRNA methylation in response to nutrient signalingIn: Nucleic Acids Research, Vol. 40, 2012, Nr. 22, pp. 11648 – 11658DOI (Open Access)
-
Small-molecule stabilization of protein-protein interactions : An underestimated concept in drug discovery?In: Angewandte Chemie International Edition, Vol. 51, 2012, Nr. 9, pp. 2012 – 2018
-
The impact of plant-pathogen studies on medicinal drug discoveryIn: Chemical Society Reviews, Vol. 41, 2012, Nr. 8, pp. 3168 – 3178
-
Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-α-independent apoptosisIn: Cancer Research, Vol. 72, 2012, Nr. 10, pp. 2645 – 2656DOI (Open Access)
-
Melanoma genome sequencing reveals frequent PREX2 mutationsIn: Nature, Vol. 485, 2012, Nr. 7399, pp. 502 – 506
-
Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2DIn: Cancer Research, Vol. 72, 2012, Nr. 2, pp. 460 – 471
-
Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsisIn: The EMBO Journal, Vol. 31, 2012, Nr. 1, pp. 201 – 213
-
Hydroxyureas as noncovalent proteasome inhibitorsIn: Angewandte Chemie International Edition, Vol. 51, 2012, Nr. 1, pp. 247 – 249
-
Brain natriuretic peptide (BNP) : A general mortality predictor in HIV-infected patients? - Results from the 5 year follow-up of the HIV-HEART trialIn: European Heart Journal, Vol. 33, 2012, Nr. Suppl. 1, pp. 337
-
Efficient pharmacological prevention of the major side effects of cisplatin without affecting the antineoplastic effiacy in vivoIn: Annals of Oncology, Vol. 23, 2012, Nr. Suppl. 1, pp. 25
-
LUX-Lung 3 : Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutationsIn: Annals of Oncology, Vol. 23, 2012, Nr. Suppl. 9, pp. 402
-
Phase IB dose-escalation study of BEZ235 or BKM 120 in combination with paclitaxel (PTX) in patients with advanced solid tumorsIn: Annals of Oncology, Vol. 23, 2012, Nr. Suppl. 9, pp. 157 – 158
-
Lux-LungG 3 : Afatinib versus cisplatin and pemetrexed in Japanese patients with adenocarcinoma of the lung harboring an EGFR mutationIn: Annals of Oncology, Vol. 23, 2012, Nr. Suppl. 11, pp. 8
-
Activity of afatinib in uncommon epidermal growth factor receptor (EGFR) mutations in Lux-Lung 3, a phase III trial of afatinib or cisplatin/pemetrexed EGFR mutation-positive lung cancerIn: Annals of Oncology, Vol. 23, 2012, Nr. Suppl. 9, pp. 410 – 411
-
Changes of peripheral alpha LPHA-Melanocortin stimulating hormone (alpha-MSH) in childhood craniopharyngioma patients in comparison with other forms of childhood obesityIn: Neuro-Oncology, Vol. 14, 2012, Nr. Suppl. 1, pp. 23
-
Vascular endothelial growth factor induces contralesional corticobulbar plasticity and functional neurological recovery in the ischemic brainIn: Acta Neuropathologica, Vol. 123, 2012, Nr. 2, pp. 273 – 284
-
Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitorsIn: Blood, Vol. 119, 2012, Nr. 22, pp. 5144 – 5154
-
MEK inhibition in BRAF-mutated melanomaIn: The New England Journal of Medicine, Vol. 367, 2012, Nr. 14, pp. 1365
-
Why not the liver instead of the kidney?In: Blood, Vol. 120, 2012, Nr. 9, pp. 1760 – 1761DOI (Open Access)
-
Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genesIn: Leukemia, Vol. 26, 2012, Nr. 1, pp. 185 – 188
-
BLUEPRINT to decode the epigenetic signature written in bloodIn: Nature Biotechnology, Vol. 30, 2012, Nr. 3, pp. 224 – 226
-
Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion VariantsIn: Clinical Cancer Research, Vol. 18, 2012, Nr. 17, pp. 4682 – 4690DOI (Open Access)
-
Interactions of calix[n]arenes with nucleic acidsIn: Nature Communications, Vol. 7, 2012, Nr. 3, pp. 409 – 417
-
DNA Origami : The Art of Folding DNAIn: Angewandte Chemie International Edition, Vol. 51, 2012, Nr. 1, pp. 58 – 66
-
The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemiaIn: Leukemia, Vol. 25, 2011, Nr. 4, pp. 638 – 647
-
The heterodimerization domains of MLL-FYRN and FYRC-are potential target structures in t(4;11) leukemia.In: Leukemia, Vol. 25, 2011, Nr. 4, pp. 663 – 670
-
Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptidesIn: Nature Communications, Vol. 2, 2011, pp. 453DOI (Open Access)
-
Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutationsIn: Nature Cell Biology, Vol. 13, 2011, Nr. 9, pp. 1116 – 1123
-
Substrate induced remodeling of the active site regulates human HtrA1 activityIn: Nature Structural & Molecular Biology, Vol. 18, 2011, pp. 386 – 388
-
The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaksIn: Nature Cell Biology, Vol. 13, 2011, Nr. 11, pp. 1376 – 1382
-
Polo-like kinase 1 is a therapeutic target in high-risk neuroblastomaIn: Clinical Cancer Research, Vol. 17, 2011, Nr. 4, pp. 731 – 741
-
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samplesIn: Clinical Cancer Research, Vol. 17, 2011, Nr. 24, pp. 7684 – 7692
-
High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary NeuroblastomaIn: Clinical Cancer Research, Vol. 17, 2011, Nr. 15, pp. 5082 – 5092
-
Regulation of DNA Replication through Sld3-Dpb11 Interaction Is Conserved from Yeast to HumansIn: Current Biology, Vol. 21, 2011, Nr. 13, pp. 1152 – 1157
-
Cleavage of cohesin rings coordinates the separation of centrioles and chromatidsIn: Nature Cell Biology, Vol. 13, 2011, Nr. 8, pp. 966 – 972
-
Covalent Tethering of Protruding Arms for Addressable DNA NanostructuresIn: Small, Vol. 7, 2011, Nr. 20, pp. 2887 – 2898
-
CD8+ T-Cell Response Promotes Evolution of Hepatitis C Virus Nonstructural ProteinsIn: Gastroenterology, Vol. 140, 2011, Nr. 7, pp. 2064 – 2073
-
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona : a comprehensive quantitative proteomic analysisIn: ACS Nano, Vol. 5, 2011, Nr. 9, pp. 7155 – 7167
-
HTRA proteases : regulated proteolysis in protein quality controlIn: Nature Reviews Molecular Cell Biology, Vol. 12, 2011, Nr. 3, pp. 152 – 162
-
Structural adaptation of the plant protease Deg1 to repair photosystem II during light exposureIn: Nature Structural & Molecular Biology, Vol. 18, 2011, Nr. 6, pp. 728 – 731
-
Functionalization of DNA nanostructures with proteinsIn: Chemical Society Reviews, Vol. 40, 2011, Nr. 12, pp. 5910 – 5921
-
Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative TherapyIn: Cancer Research, Vol. 71, 2011, Nr. Suppl. 24
-
G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligandsIn: Blood, Vol. 117, 2011, Nr. 16, pp. 4349 – 4357
-
Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infectionsIn: Nature Medicine, Vol. 17, 2011, Nr. 3, pp. 341 – 346
-
Protein quality control in the bacterial periplasmIn: Annual Review of Microbiology, Vol. 65, 2011, pp. 149 – 168
-
Sphingosine-1-Phosphate Receptor 3 Promotes Recruitment of Monocyte/Macrophages in Inflammation and AtherosclerosisIn: Circulation Research, Vol. 108, 2011, Nr. 3, pp. 314 – 323DOI (Open Access)
-
IL-IR/MyD88 Signalling Mediates Severity of UC-Like Pancolitis in TLR2/MDRIA Double Deficient MiceIn: Gastroenterology, Vol. 140, 2011, Nr. 5 Suppl. 1, pp. S143 – S144
-
Growth Factor Independence 1 (Gfi1) Regulates Cell-Fate Decision of the Bipotential Granulocytic-Monocytic Precursors Defined by Expression of CD48 As a New MarkerIn: Blood, Vol. 118, 2011, Nr. 21, pp. 1389
-
Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndromeIn: Nature Genetics, Vol. 43, 2011, Nr. 1, pp. 20 – 22
-
Mast Cells Are Key Promoters of Contact Allergy that Mediate the Adjuvant Effects of HaptensIn: Immunity, Vol. 34, 2011, Nr. 6, pp. 973 – 984DOI (Open Access)
-
Anthropogenic greenhouse gas contribution to flood risk in England and Wales in autumn 2000In: Nature, Vol. 470, 2011, Nr. 7334, pp. 382 – 385
-
Post-irradiation chemical processing of DNA damage generates double-strand breaks in cells already engaged in repairIn: Nucleic Acids Research, Vol. 39, 2011, Nr. 19, pp. 8416 – 8429DOI (Open Access)
-
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk : evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patientsIn: Blood, Vol. 118, 2011, Nr. 5, pp. 1402 – 1412DOI (Open Access)
-
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma : A multicenter phase II DeCOG trialIn: Annals of Oncology, Vol. 22, 2011, Nr. 7, pp. 1667 – 1674
-
A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF : a study of the SAA Working Party of the European Group for Blood and Marrow TransplantationIn: Blood, Vol. 117, 2011, Nr. 17, pp. 4434 – 4441
-
Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon CancerIn: Gastroenterology, Vol. 141, 2011, Nr. 6, pp. 2154 – 2165
-
Elucidation of the α-keto-aldehyde binding mechanism : A lead structure motif for proteasome inhibitionIn: Angewandte Chemie International Edition, Vol. 50, 2011, Nr. 2, pp. 542 – 544
-
Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological AttenuationIn: Circulation Research, Vol. 108, 2011, Nr. 3, pp. 344 – 352DOI (Open Access)
-
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphomaIn: Leukemia, Vol. 25, 2011, Nr. 12, pp. 1797 – 1807
-
Enhancement of endogenous neurogenesis in ephrin-B3 deficient mice after transient focal cerebral ischemiaIn: Acta Neuropathologica, Vol. 122, 2011, Nr. 4, pp. 429 – 442DOI (Open Access)
-
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adultsIn: Blood, Vol. 118, 2011, Nr. 1, pp. 139 – 147
-
Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPCIn: Blood, Vol. 117, 2011, Nr. 18, pp. 4905 – 4914DOI (Open Access)
-
Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationIn: The New England Journal of Medicine, Vol. 364, 2011, Nr. 26, pp. 2507 – 2516
-
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemiaIn: Leukemia, Vol. 24, 2010, Nr. 6, pp. 1152 – 1159
-
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signatureIn: Clinical Cancer Research, Vol. 16, 2010, Nr. 5, pp. 1532 – 1541
-
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastomaIn: Nucleic Acids Research, Vol. 38, 2010, Nr. 17, pp. 5919 – 5928
-
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastomaIn: Clinical Cancer Research, Vol. 16, 2010, Nr. 11, pp. 2971 – 2978
-
A Scaffold-Tree-Merging Strategy for Prospective Bioactivity Annotation of γ-PyronesIn: Angewandte Chemie International Edition, Vol. 49, 2010, Nr. 21, pp. 3666 – 3670
-
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplificationIn: Clinical Cancer Research, Vol. 16, 2010, Nr. 17, pp. 4353 – 4362
-
ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast CancerIn: Clinical Cancer Research, Vol. 16, 2010, Nr. 2, pp. 451 – 460
-
Ipilimumab monotherapy in patients with pretreated advanced melanoma : a randomised, double-blind, multicentre, phase 2, dose-ranging studyIn: The Lancet Oncology, Vol. 11, 2010, Nr. 2, pp. 155 – 164
-
SiRNA-loaded multi-shell nanoparticles incorporated into a multilayered film as a reservoir for gene silencingIn: Biomaterials, Vol. 31, 2010, Nr. 23, pp. 6013 – 6018
-
The use of calcium phosphate nanoparticles encapsulating toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activationIn: Biomaterials, Vol. 31, 2010, Nr. 21, pp. 5627 – 5633
-
Orthogonal Protein Decoration of DNA OrigamiIn: Angewandte Chemie International Edition, Vol. 49, 2010, Nr. 49, pp. 9378 – 9383
-
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemiaIn: Blood, Vol. 115, 2010, Nr. 12, pp. 2462 – 2472
-
Evidence of an adaptive response targeting DNA nonhomologous end joining and its transmission to bystander cellsIn: Cancer Research, Vol. 70, 2010, Nr. 21, pp. 8498 – 8506
-
Determinants of structural and functional plasticity of a widely conserved protease chaperone complexIn: Nature Structural & Molecular Biology, Vol. 17, 2010, Nr. 7, pp. 837 – 843
-
The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in NeuroblastomaIn: Molecular Cell, Vol. 40, 2010, Nr. 5, pp. 762 – 773
-
HtrA proteases have a conserved activation mechanism that can be triggered by distinct molecular cuesIn: Nature Structural & Molecular Biology, Vol. 17, 2010, Nr. 7, pp. 844 – 852
-
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancerIn: Genes and Development, Vol. 24, 2010, Nr. 8, pp. 837 – 852
-
Mutations of CARD11 but not TNFAIP3 may activate the NF-κB pathway in primary CNS lymphomaIn: Acta Neuropathologica, Vol. 120, 2010, Nr. 4, pp. 529 – 535
-
Design of a minimal silencer for the silent mating-type locus HML of Saccharomyces cerevisiaeIn: Nucleic Acids Research, Vol. 38, 2010, Nr. 22, pp. 7991 – 8000DOI (Open Access)
-
Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heartIn: Circulation, Vol. 121, 2010, Nr. 8, pp. 989 – 996
-
Genomic imbalances in Hodgkin lymphomaIn: Blood, Vol. 116, 2010, Nr. 3, pp. 309 – 311DOI (Open Access)
-
PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cellsIn: Blood, Vol. 116, 2010, Nr. 9, pp. 1454 – 1459
-
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancerIn: Annals of Oncology, Vol. 21, 2010, Nr. 2, pp. 275 – 282
-
Improved Survival with Ipilimumab in Patients with Metastatic MelanomaIn: The New England Journal of Medicine, Vol. 363, 2010, Nr. 8, pp. 711 – 723
-
Transcription Factor Miz-1 Is Required to Regulate Interleukin-7 Receptor Signaling at Early Commitment Stages of B Cell DifferentiationIn: Immunity, Vol. 33, 2010, Nr. 6, pp. 917 – 928DOI (Open Access)
-
Inhibition of hyaluronan synthesis accelerates murine atherosclerosis : Novel insights into the role of hyaluronan synthesisIn: Circulation, Vol. 122, 2010, Nr. 22, pp. 2313 – 2322
-
Lipids control mucus production in cystic fibrosisIn: Nature Medicine, Vol. 16, 2010, Nr. 3, pp. 267 – 268
-
Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cellsIn: Blood, Vol. 116, 2010, Nr. 20, pp. 4202 – 4211DOI (Open Access)
-
705 Increased prevalence of monoclonal b lymphocytosis in patients with chronic Hepatitis CIn: Journal of Hepatology, Vol. 52, 2010, Nr. Suppl. 1, pp. S274
-
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma : implications for therapyIn: Cancer Research, Vol. 69, 2009, Nr. 5, pp. 2065 – 2071DOI (Open Access)
-
Coordination of Rho GTPase activities during cell protrusionIn: Nature, Vol. 461, 2009, Nr. 7260, pp. 99 – 103
-
Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compoundsIn: Clinical Cancer Research, Vol. 15, 2009, Nr. 11, pp. 3690 – 3696
-
Dendritic DNA Building Blocks for Amplified Detection Assays and BiomaterialsIn: Angewandte Chemie International Edition, Vol. 48, 2009, Nr. 33, pp. 5996 – 6000
-
RASSF1A mediates p21Cip1/Waf1- dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of AktIn: Cancer Research, Vol. 69, 2009, pp. 1748 – 1757
-
The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfectionIn: Biomaterials, Vol. 30, 2009, Nr. 35, pp. 6794 – 6802
-
Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteriaIn: Biomaterials, Vol. 30, 2009, Nr. 19, pp. 3324 – 3331
-
Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumorsIn: Cancer Research, Vol. 69, 2009, Nr. 17, pp. 6941 – 6950DOI (Open Access)
-
The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinomaIn: Annals of Oncology, Vol. 20, 2009, Nr. 6, pp. 1094 – 1099DOI (Open Access)
-
CD4⁺Foxp3⁺ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cellsIn: Gut, Vol. 58, 2009, Nr. 2, pp. 211 – 219
-
High-Throughput, Real-Time Monitoring of the Self-Assembly of DNA Nanostructures by FRET SpectroscopyIn: Angewandte Chemie International Edition, Vol. 47, 2008, Nr. 11, pp. 2135 – 2137
-
Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cellsIn: Clinical Cancer Research, Vol. 14, 2008, Nr. 4, pp. 1172 – 1181
-
From metal complexes to nanominerals : the formation of inorganic nanoparticles on fibrils of transferrinIn: Angewandte Chemie International Edition, Vol. 47, 2008, Nr. 27, pp. 4960 – 4961
-
Structural basis for the regulated protease and chaperone function of DegP.In: Nature, 2008, Nr. 453, pp. 885 – 890
-
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.In: Science, Vol. 5891, 2008, Nr. 321, pp. 974 – 977
-
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxinsIn: Nature, Vol. 453, 2008, Nr. 7191, pp. 106 – 109DOI, Online Full Text (Open Access)
-
Survivin determines cardiac function by controlling total cardiomyocyte numberIn: Circulation, Vol. 117, 2008, Nr. 12, pp. 1583 – 1593
-
X-ray Microcomputer Tomography for the Study of Biomineralized Endo- and Exoskeletons of AnimalsIn: Chemical Reviews, Vol. 108, 2008, Nr. 11, pp. 4734 – 4741
-
X-ray micro computer tomography for the study of bio¬minera¬lized endo- and exoskeletons of animalsIn: Chemical Reviews, Vol. 108, 2008, pp. 4734 – 4741
-
Calcium phosphate crystals induce cell death in human vascular smooth muscle cells : A potential mechanism in atherosclerotic plaque destabilizationIn: Circulation Research, Vol. 103, 2008, pp. e28 – e32
-
Targeting AKT signaling sensitizes cancer to cellular immunotherapyIn: Cancer Research, Vol. 68, 2008, pp. 3899 – 3906
-
Allosteric activation of HtrA protease DegP by stress signals during bacterial protein quality controlIn: Angewandte Chemie International Edition, Vol. 47, 2008, Nr. 7, pp. 1332 – 1334
-
Inorganic nanoparticles as carriers of nucleic acids into cellsIn: Angewandte Chemie International Edition, Vol. 47, 2008, Nr. 8, pp. 1382 – 1395
-
A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanismIn: Nature, Vol. 452, 2008, pp. 755 – 758
-
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosisIn: Nature Medicine, Vol. 14, 2008, Nr. 4, pp. 382 – 391DOI (Open Access)
-
Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 geneIn: Clinical Cancer Research, Vol. 14, 2008, Nr. 6, pp. 1753 – 1758DOI (Open Access)
-
Histone H1 functions as a stimulatory factor in backup pathways of NHEJIn: Nucleic Acids Research, Vol. 36, 2008, Nr. 5, pp. 1610 – 1623DOI, Online Full Text (Open Access)
-
Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin.In: Nucleic Acids Research, Vol. 36, 2008, Nr. 17, pp. 5678 – 5694DOI (Open Access)
-
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosisIn: Blood, Vol. 112, 2008, Nr. 8, pp. 3312 – 3321DOI, Online Full Text (Open Access)
-
Biglycan is required for adaptive remodeling after myocardial infarctionIn: Circulation, Vol. 117, 2008, Nr. 10, pp. 1269 – 1276DOI (Open Access)
-
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infectionIn: Journal of Hepatology, Vol. 48, 2008, Nr. 1, pp. 83 – 90
-
Regulation of the σE stress response by DegS: How the PDZ domain keeps the protease inactive in the resting state and allows integration of different OMP-derived stress signals upon folding stressIn: Genes and Development, Vol. 21, 2007, Nr. 20, pp. 2659 – 2670
-
Determinants of regulated proteolysis in signal transductionIn: Genes and Development, Vol. 21, 2007, Nr. 1, pp. 6 – 10
-
Essential CDK1-inhibitory role for separase during meiosis I in vertebrate oocytesIn: Nature Cell Biology, Vol. 8, 2006, Nr. 9, pp. 1035 – 1037
-
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicityIn: The Journal of Clinical Investigation (JCI), Vol. 116, 2006, Nr. 7, pp. 1994 – 2004
-
Control of replication initiation and heterochromatin formation in Saccharomyces cerevisiae by a regulator of meiotic gene expressionIn: Genes and Development, Vol. 19, 2005, Nr. 15, pp. 1811 – 1822
-
Length-dependent energetics of (CTG)n and (CAG)n trinucleotide repeatsIn: Nucleic Acids Research, Vol. 33, 2005, Nr. 13, pp. 4065 – 4077
-
Kinetics of tetramolecular quadruplexesIn: Nucleic Acids Research, Vol. 33, 2005, Nr. 1, pp. 81 – 94
-
Mutual inhibition of separase and Cdk1 by two-step complex formationIn: Molecular Cell, Vol. 19, 2005, Nr. 1, pp. 135 – 141DOI (Open Access)
-
The effect of chemical modifications on the thermal stability of different G-quadruplex-forming oligonucleotidesIn: Nucleic Acids Research, Vol. 33, 2005, Nr. 4, pp. 1182 – 1192
-
Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a proteaseIn: Cell, Vol. 117, 2004, Nr. 4, pp. 483 – 494
-
Proteolysis as a regulatory mechanismIn: Annual Review of Genetics, Vol. 38, 2004, pp. 709 – 724